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With the pandemic proportions of obesity and a correlative increase in  fatty liver disease, 
there was a dire need to explore the missing link between the changed environment and  
progression of NAFLD in obesity. My research implies that environmental toxin 
bromodichloromethane induces early liver lesions in obesity, and is mediated by the 
synchronous insult of oxidative stress and increased levels of the adipokine leptin. In a 
two-pronged approach to investigate the molecular cues, I looked at the role of Purinergic 
receptor X7 and Toll 4 receptor. Both rodent models and cell-based systems were used. 
Also, in order to validate my findings in humans, I used diseased liver samples and 
corresponding age-matched controls. All diseased samples, and toxin-primed cell systems 
tested positive for oxidative stress markers. My first set of findings strongly suggest that 
P2X7r is a key regulator of autophagy-induced metabolic oxidative stress and early liver 
inflammation. In the second part of my investigation, I observed that toll 4 receptor 
recruitment to raft-zones of the liver cell membranes is crucial for its induction and 
inflammation in NAFLD. Most importantly, instead of the well-established stimulator of 
toll-receptor 4, LPS, I show that peroxynitrite which is elevated in the system as a result of 
the free radical chemistry, post environmental toxin exposure, is a potent inducer of TLR4-
mediated inflammation in the disease. High-end confocal microscopy and 
immunofluorescence imaging techniques were utilized in addition to quantifying gene 
expressions, and immunoblotting proteins. Also, in a first-ever report in any model of 
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NAFLD I used a peroxynitite-scavenging molecule FBA, showing positive remediation of 
NAFLD symptoms. This could be a very promising treatment regimen for redox-toxicity 
driven NAFLD. In conclusion, this novel disease model of NAFLD, helps us better 
understand the environmental link to the disease in presence of obesity, and exemplifies 
the molecular cues as potential therapeutic targets for alleviation of this silent-killer. 
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PREFACE 
Obesity is a widespread disease/ syndrome in the modern world.  Steatosis of liver (fatty 
liver) is common in approximately seventy-five percent of obese subjects and around 
twenty percent of these individuals develop inflammatory liver disease. Non-alcoholic 
fatty liver disease (NAFLD) is a spectrum where the liver progresses from fat 
accumulation, to necroinflammation, to scarring of liver tissue (fibrosis). The advanced 
stage of  the NAFLD spectrum, nonalcoholic steatohepatitis (NASH), is marked by 
necroinflammation, release of proinflammatory cytokines and some degrees of fibrosis. 
NASH if untreated, can lead to cirrhosis, hepatocellular carcinoma and autoimmune 
disorders owing to the highly inflamatory microenvironment. The progression of steatosis 
to steatohepatitis can be very rapid and is characterized by infiltration of macrophages, 
activation of Kupffer cells (resident macrophages in the liver), apoptosis leading to 
necrosis, Mallory Body formation, and degeneration of hepatocytes.  
This progression can be promoted by a second hit, brought on by reductive metabolism of 
environmental  toxicants in water, diet and air. Our laboratory has shown evidence of 
NASH being caused by reductive metabolism of disinfection byproducts via CYP2E1, in 
presence  of high fat diet. Chlorine-based disinfectants have played a critical role in 
protecting drinking water supplies from water-borne infectious diseases for nearly a 
century.  
Bromodichloromethane belongs to a wide range of chemicals known as trihalomethanes, 
which are formed after chlorine, is added to the water for disinfection. The possible
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exposure routes to BDCM are by  ingestion (through drinking water), by inhalation and/or 
by dermal absorption. Reports suggest that the maximum exposure can occur through oral 
and dermal route. BDCM is metabolized by the CYP450 enzyme primarily present in the 
microsomes of hepatocytes. The toxic effects of BDCM are mediated by the reductive free 
radical metabolism of this compound by CYP2E1, an isoform of cytochrome P450 enzyme, 
forming highly toxic hydroxenonenal adducts that cause hepatocellular necrosis (Das S et 
al, Toxicol Appl Pharm; Seth R et al, Tox Sciences, Chatterjee Lab, 2013). Also, since this 
model of NASH is derived from chronic exposure to drinking water disinfection byproduct 
and is an example of ad libitum exposure, I have used the phrase redox-toxicity driven 
environmental NAFLD or  NASH (Seth R et al, Chatterjee Lab, Toxicological Sciences, 
2013).  
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During the past decade, rates of obesity including childhood and adolescent obesity have 
been on the rise, and associated co-morbidities like Non-alcoholic fatty liver disease are 
looming large. Risk factors such as diet composition, excess caloric intake, decreased 
exercise, genetics, and the built environment are perceived as causes of obesity and 
associated co-morbidities (1) (2). Obesity is considered as a low inflammatory condition, 
following a number of studies in the last decade (3). The increased blood levels of 
proinflammatory cytokines and adipokines such as leptin influence the inflammatory state 
in obesity (4). Obesity associated co-morbidities include lung, liver and cardiovascular 
complications (2). In parallel, it is perceived that with increased obesity there is also an 
increase in liver disorders like non alcoholic steatohepatitis, cirrhosis and in extreme cases 
hepatocarcinoma (5). I felt a dire need to find the missing link between the changes in the 
environment and the increasing incidences of fatty liver disease in obesity, and hence my 
research in this field. I investigated one of the most common sources of environmental 
toxicant, drinking water. Several hypotheses have been put forward for the progression of 
fatty liver to inflammatory liver disease in obesity. The two hit hypothesis and the multi 
factorial hypothesis point to a secondary assault apart from obesity to be a relevant cause 
for liver diseases (6, 7). In recent literature, our laboratory and others have shown that CCl4 
exposure, albeit in lower doses can sensitize obese liver to hepatotoxicity and development 
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of early steatohepatitic injury (4, 8). A recent study from Cave M et al. shows the 
involvement of the built environment in development of liver diseases in humans (9). The 
study explicitly shows the association of polychlorinated biphenyls and heavy metals to 
non alchoholic steatohepatitis in American adults. Lately the involvement of cytochrome 
P450s in the metabolism of these environmental toxicants has been an active area of 
research (10, 11). The role of CYP2E1 has been extensively studied and it has been found 
to have a close association with reactive oxygen species generation and development of 
steatohepatitic injury (12). Research by our Principal Investigator has shown previously 
that free radical metabolism of the model toxin CCl4 by CYP2E1 causes the release of 
damage associated molecular patterns (DAMPS) and increased release of leptin from both 
hepatic and adipose tissues (8). These studies assume significance since both reactive 
oxygen species (ROS) and leptin have been found to exacerbate the progression of steatosis 
to steatohepatitis in obesity (12), (13) Similar to CCl4, which produces trihalomethyl 
radicals upon metabolism by CYP2E1, several trihalomethanes have been found to be 
metabolized by CYP2E1 to produce noxious free radicals (14-16). The disinfection 
byproducts of drinking water which are formed from reaction with the bromine in water 
following chlorine disinfection, produce ROS (16). Although direct exposure to high doses 
of environmental toxins is rare, low exposures from the environment are far more common. 
These doses may be well-tolerated by normal healthy individuals but can be potential risk 
factors for inflammatory liver injuries such as steatohepatitis in obese persons. This risk 
assumes significance in terms of public health because there is presently an alarming rise 
in obesity in the United States alone. The National Toxicological program identifies several 
disinfection byproducts for drinking water that are hepatotoxic (16-18) and are bioactivated 
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by liver cytochrome p450 enzymes leading to generation of free radicals (15, 16). The 
resulting oxidative stress from the reductive metabolism of CHBrCl2 can lead to 
amplification of hepatotoxicity by triggering host innate immune responses. Innate 
immune events such as activation of macrophages through secretion of an array of 
cytokines can amplify the risk of developing full-blown inflammatory disease like early 
steatohepatitic injury leading to fibrosis and cirrhosis if exposed on a chronic basis. 
Leptin is a 167-amino acid protein discovered in 1994 by positional cloning of the 
ob gene (2) (2, 19). Though it is considered to be an anorexigenic hormone, its levels are 
elevated in obesity as a result of resistance to its actions in the hypothalamus, a condition 
called central resistance (20). Leptin is thought to contribute, in part, to NASH 
development in obesity through its proinflammatory actions on sinusoidal epithelial cells 
and Kupffer cells (4, 21-23). Recent lines of evidence support a role of  the elevated levels 
of leptin found in obesity in generating reactive oxygen and reactive nitrogen species and 
subsequent free radical formation (24). Free radical production appears to contribute to the 
progression of steatohepatitis and its resultant hepatotoxicity (25). The presence of high 
levels of leptin in obesity certainly makes it a prime candidate for amplifying the risk of 
NASH progression as both a first and second hit, which not only satisfies the two hit 
hyposthesis, but also is in line with the multi hit paradigm(7). My studies as noted in 
Chapter 2, and other studies from our laboratory have demonstrated that leptin mediates 
the effect on NASH progression through peroxynitrite formation and Kupffer cell 
activation in a toxin model of NASH.  
Nonalcoholic steatohepatitis (NASH) is associated with metabolic oxidative stress, 
often ascribed to enhanced oxidation of membrane lipids, mitochondrial uncoupling of the 
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electron transport chain and higher cytochrome P450 enzyme activity (11, 26, 27). 
Metabolic oxidative stress leads to cellular stress and induce cell death mechanisms which 
modulate inflammatory microenvironment in NASH (8, 28).  
Cell death mechanisms in disease pathogenesis are synonymous with necrosis, 
autophagy and apoptosis, however much attention is recently focused on the various roles 
of autophagy in cellular processes, inflammation, energy homeostasis and immunity (29, 
30). In spite of increased attention on autophagy, the mechanisms that control autophagy 
in NASH remain unclear. Autophagy is a central eukaryotic process with many 
cytoplasmic homeostatic roles (30). It is a critical pathway for degradation of intracellular 
components by lysosomes and has established roles in hepatic lipid metabolism, insulin 
sensitivity and cellular injury (31). Autophagy, dependent upon the involvement of the 
cellular components has been classified into macro, micro and chaperone mediated 
autophagy (CMA). It is crucial though, that these processes rely on formation of 
autophagosomes, increased levels of LC3B, fusion of autophagosome with the lysosome 
and degradation of the cellular cargo by lysosomal enzymes (31-34). Given the importance 
of autophagy in cellular homeostasis and disease pathogenesis it is also important to study 
both the inducers and regulators of autophagy in a pathological state like NASH. One of 
the key components of the inflammatory microenvironment in various disease pathologies 
is the ionotrophic purinergic receptors (P2 receptors) which respond to the damage 
associated molecular patterns (DAMPs) (35, 36). There is an increased focus on a subclass 
of these receptors (P2X7 receptor) which bind ATP with high affinity and is known to 
regulate inflammation in early steatohepatitic injury in mice (8). Apart from the binding to 
ATP, P2X7 receptor (P2X7r) has been shown to increase NADPH oxidase activity, 
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increase Kupffer cell-MHC class II expression and regulate inflammation (8). With 
increased focus on purinergic receptors, inflammosome activation and autophagy in 
NASH, I explored the possibility of P2X7r as a key regulator of autophagy and the resultant 
inflammation in NASH, as recorded in my first-authored manuscript in Chapter 3. 
Nonalcoholic steatohepatitis (NASH) has been studied extensively in preclinical 
models and humans. NASH manifestations range from an early sinusoidal endothelial 
dysfunction, inflammation followed by a defective tissue repair resulting in fibrosis(37-
42). Inefficient tissue perfusion in the fatty tissue mostly associated with fatty liver and 
subsequent NASH progression can result in recruitment of other cell types including 
Kupffer cells, sinusoidal endothelial cells and circulating lymphocytes, making it a perfect 
microenvironment for forming an inflammatory foci (43).  
Recent research reports identify an emerging role of toll like receptor 4 in NASH 
pathogenesis(44, 45). Several endogenous mediators like gut derived endotoxin and 
nuclear factor HMGB-1 has been implicated to activate TLR4 signaling leading to NASH 
severity(46, 47). After its discovery in the 1980s, toll like receptor signaling has been in 
the forefront of innate immune signaling and disease pathophysiology (48). TLR4, one of 
the many TLRs discovered since then plays a pivotal role in cytokine release along with its 
adaptor molecules myeloid differentiation primary response gene 88 (MyD88) and TIR-
domain-containing adapter-inducing interferon-β (TRIF). MyD88 was found to work as an 
adaptor for inflammatory signaling pathways downstream of members of the TLR and 
interleukin-1 (IL-1) receptor families(49). Activation of the TLR4 pathway leads to a 
variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), 
mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node 
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of inflammatory pathways(49) . Lipopolysaccharide of gram negative bacterial cell walls 
is a strong ligand for TLR4 on the cell membrane. MD-2 is associated with Toll-like 
receptor 4 (TLR4) on the cell surface and enables TLR4 to respond to LPS (50). Deficiency 
of MyD88 or TLR4 in mice have attenuated the development of the disease(51). Though 
oxidative stress via NADPH oxidase has been shown to drive NASH pathogenesis 
especially fibrogenesis and Kupffer cell activation, there is no direct evidence of a single 
mechanism where a specific oxidative species can drive the recruitment of TLR4-mediated 
inflammation in NASH(13, 24, 52). I , in my study recorded in Chapter therefore aim to 
identify a single intracellular reactive nitrative species that may play a distinct role in 
developing the inflammatory pathogenesis in NASH via TLR4 recruitment to hepatic lipid 
rafts, an early yet distinct process in TLR4 activation and downstream signaling. One of 
the common sources of generation of toxic superoxide radicals may be NADPH oxidase 
isoforms which can be found in both phagocytic and non-phagocytic cells(53). Liver has 
been shown to be a rich source of various NOX isoforms, being present in phagocytic 
Kupffer cells, stellate cells and sinusoidal endothelial cells (39, 52, 54). Out of the various 
NOX isoforms NOX2 is primarily present in Kupffer cells and stellate cells whereas NOX1 
and NOX4 have been found in other liver cell types(52). NOX2 is comprised of several 
subunits which includes the gp91, p22 (membrane subunits), p67, p47 and Rac1 (cytosolic 
subunits)(53). Upon receipt of proper signals, the cytosolic subunits align with their 
membrane counterparts to form an active NADPH oxidase complex which produce 
superoxide radicals to be released in the extracellular space(53). Several laboratories 
including us have shown the involvement of NOX2 in NASH development(13, 24, 54). 
NOX2 stimulation by high leptin results in peroxynitrite generation thus causing Kupffer 
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cell activation in NASH(13). NOX2 has also been shown to facilitate recruitment of toll-
like receptor 4 to lipid rafts and to help in receptor dimerization and its association with 
MD2 in several inflammatory diseases(55). Since there is no evidence of the molecular 
events that follow NADPH oxidase activation concerning the type of reactive species 
formation and the mechanisms that link TLR4 activation, I investigated the role of 
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Abstract:  
Today’s developed world faces a major public health challenge in a rise in obese population 
and an increased incidence in fatty liver disease. There is a strong association among diet 
induced obesity, fatty liver disease and development of nonalcoholic steatohepatitis but the 
environmental link to disease progression remains unclear. Here we demonstrate that water 
disinfection byproduct bromodichloromethane-induced early steatohepatitic lesions in 
obesity, is mediated by increased oxidative stress and leptin which act in synchrony to 
potentiate disease progression. Low acute exposure of bromodichloromethane (BDCM), in 
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diet induced obesity produced oxidative stress as shown by increased lipid peroxidation, 
protein free radical and nitrotyrosine formation and elevated leptin levels. Exposed obese 
mice showed histopathological signs of early steatohepatitic injury and necrosis. 
Spontaneous knockout mice for leptin or systemic leptin receptor knockout mice had 
significantly decreased oxidative stress and TNF-α  levels. Co-incubation of leptin and 
BDCM caused Kupffer cell activation as shown by increased MCP-1 release and NADPH 
oxidase membrane assembly, a phenomenon that was decreased in Kupffer cells isolated 
from leptin receptor knockout mice. There was a significant increase in Kupffer cell 
activation marker CD68 in livers of obese mice that were BDCM exposed and showed 
increased necrosis as assessed by levels of isocitrate dehydrogenase, an event that was 
decreased in the absence of leptin or its receptor. In conclusion our results show that 
disinfection byproduct BDCM exposure in diet induced obesity augments steatohepatitic 
injury by potentiating effects of leptin on oxidative stress, kupffer cell activation and cell 
death in the liver. 
2.1 INTRODUCTION 
Childhood and adolescent rates of obesity and overweight have assumed pandemic 
proportions in the last decade. Risk factors such as diet composition, excess caloric intake, 
decreased exercise, genetics, and the built environment are perceived as causes of obesity 
and associated co-morbidities (1) (2). Obesity is considered as a low inflammatory 
condition, following a number of studies in the last decade (3). The increased blood levels 
of proinflammatory cytokines and adipokines such as leptin influence the inflammatory 
state in obesity (4). Obesity associated co-morbidities include lung, liver and 
cardiovascular complications (2). In parallel, it is perceived that with increased obesity 
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there is also an increase in liver disorders like nonalcoholic steatohepatitis, cirrhosis and in 
extreme cases hepatocarcinoma (5). Several hypotheses have been put forward for the 
progression of fatty liver to inflammatory liver disease in obesity. The two hit hypothesis 
and the multi factorial hypothesis point to a secondary assault apart from obesity to be a 
relevant cause for liver diseases (6, 7). In recent literature, we and others have shown that 
CCl4 exposure, albeit in lower doses can sensitize obese liver to hepatotoxicity and 
development of early steatohepatitic injury (4, 8). A recent study from Cave M et al. shows 
the involvement of the built environment in development of liver diseases in humans (9). 
The study explicitly shows the association of polychlorinated biphenyls and heavy metals 
to non alchoholic steatohepatitis in American adults. Lately the involvement of cytochrome 
p 450s in the metabolism of these environmental toxicants has been an active area of 
research (10, 11). The role of CYP2E1 has been extensively studied and it has been found 
to have a close association with reactive oxygen species generation and development of 
steatohepatitic injury(12). Our research has shown previously that free radical metabolism 
of the model toxin CCl4 by CYP2E1 causes the release of damage associated molecular 
patterns (DAMPS) and increased release of leptin from both hepatic and adipose tissues(8). 
These studies assume significance since both reactive oxygen species (ROS) and leptin 
have been found to exacerbate the progression of steatosis to steatohepatitis in obesity(12), 
((13) Similar toCCl4, which produces trihalomethyl radicals upon metabolism by CYP2E1, 
several trihalomethanes have been found to be metabolized by CYP2E1 to produce noxious 
free radicals (14-16). The disinfection byproducts of drinking water which are formed from 
reaction with the bromine in water following chlorine disinfection, produce ROS (16). 
Although direct exposure to high doses of environmental toxins is rare, low exposures from 
12 
 
the environment are far more common. These doses may be well-tolerated by normal 
healthy individuals but can be potential risk factors for inflammatory liver injuries such as 
steatohepatitis in obese persons. This risk assumes significance in terms of public health 
because there is presently an alarming rise in obesity in the United States alone. The 
National Toxicological program identifies several disinfection byproducts for drinking 
water that are hepatotoxic (16-18) and are bioactivated by liver cytochrome p450 enzymes 
leading to generation of free radicals (15, 16). The resulting oxidative stress from the 
reductive metabolism of CHBrCl2 can lead to amplification of hepatotoxicity by triggering 
host innate immune responses. Innate immune events such as activation of macrophages 
through secretion of an array of cytokines can amplify the risk of developing full-blown 
inflammatory disease like early steatohepatitic injury leading to fibrosis and cirrhosis if 
exposed on a chronic basis. 
Leptin is a 167-amino acid protein discovered in 1994 by positional cloning of the 
ob gene (2) (2, 19). Though it is considered to be an anorexigenic hormone, its levels are 
elevated in obesity as a result of resistance to its actions in the hypothalamus, a condition 
called central resistance (20). Leptin is thought to contribute, in part, to NASH 
development in obesity through its proinflammatory actions on sinusoidal epithelial cells 
and Kupffer cells (4, 21-23). Recent lines of evidence support a role of  the elevated levels 
of leptin found in obesity in generating reactive oxygen and reactive nitrogen species and 
subsequent free radical formation (24). Free radical production appears to contribute to the 
progression of steatohepatitis and its resultant hepatotoxicity(25). The presence of high 
levels of leptin in obesity certainly makes it a prime candidate for amplifying the risk of 
NASH progression as both a first and second hit, which not only satisfies the two hit 
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hyposthesis, but also is in line with the multi hit paradigm(7). Our own studies have 
demonstrated that leptin mediates the effect on NASH progression through peroxynitrite 
formation and Kupffer cell activation in a toxin model of NASH.  
Our study tests the hypothesis that low bromodichloromethane exposure, which has been 
studied for the formation of dihalomethyl radicals in ESR studies, produces ROS in obese 
liver and the resultant oxidative stress links early steatohepatic injury. We also examine 
the role of leptin in mediating the progression of simple steatosis to early staetohepatitic 
injury following acute BDCM exposure. We show here, in a first ever report, the direct 
role of BDCM in inducing steatohepatitic injury in obese mice liver through the 
involvement of increased leptin resulting in Kupffer cell activation, TNF-α  release and 
cell death. 
2.2 MATERIALS AND METHODS 
Materials: The spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was obtained from 
Dojindo  Molecular Technologies, Kumamoto, Japan. Bromodichloromethane, 
Collagenase Type IV, apocynin and gadolinium chloride (GdCl3) were purchased from 
Sigma Chemical Company, St Louis, MO. Tempol was purchased from Sigma. Mouse 
recombinant leptin and neutralizing antibody to mouse leptin were purchased from R&D 
Systems,(R&D Systems Inc, Minneapolis, MN). All other chemicals were of analytical 
grade and were purchased from Sigma Chemical Company or Roche Molecular 
Biochemicals (Mannheim, Germany). All aqueous solutions were prepared using water 
passed through a Picopure 2UV Plus system (Hydro Services and Supplies, Inc., RTP, NC) 
equipped with a 0.2 m pore size filter.  
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Obese mice: Custom DIO adult male, pathogen-free, 10-week-old mice with a 
C57BL6/J background (Jackson Laboratories, Bar Harbor, Maine) were used as models of 
diet-induced obesity. The mice were fed with a high fat diet (60% kcal) from 6 weeks until 
16 weeks. All experiments were conducted in the 16-week age group.  Age-matched lean 
controls were fed with a diet having 10% kcal fat. The animals were housed one to a cage 
before any experimental use. Mice that contained the disrupted OB gene (leptin) (B6.V-
Lep<ob>/J ) (Jackson Laboratories ) and disrupted DB gene (leptin receptor) (B6.BKS(D)-
Lepr<db>/J) were fed with a high fat diet and treated identically to DIO obese mice. Mice 
had ad libitum access to food and water and were housed in a temperature-controlled room 
at 23-24 C with a 12-hour light/dark cycle. All animals were treated in strict accordance 
with the NIH Guide for the Humane Care and Use of Laboratory Animals, and the 
experiments were approved by the institutional review board both at NIEHS and the 
University of South Carolina at Columbia.  
Induction of liver injury in obese mice: DIO mice or high fat-fed gene-specific 
knockout mice at 16 weeks were administered Bromodichloromethane (2.0mmoles/kg, 
diluted in olive oil) through the intraperitoneal route.  
Isolation of Kupffer cells:  Kupffer cells were isolated as per the protocol by Froh, 
et al. (Current Protocols in Toxicology, 14.4.1-14.4.12, 2002) with some modifications. 
Briefly, mice were anesthetized and their livers were perfused initially by sterile HBSS and 
later by 0.03% collagenase at a flow rate of 5 ml/minute. Following perfusion, the liver 
was dissected and incubated with 0.03% collagenase for another 30 minutes at 37°C. The 
tissue was minced and cells were extracted with a syringe piston. The cell suspension was 
filtered through a 75µ cell strainer (BD Falcon). The resultant single cell suspension was 
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centrifuged at 50g for 3 minutes to obtain parenchymal cells (mostly hepatocytes). The 
supernatant was further centrifuged at 650xg and the pellet was resuspended in 10 ml of 
HBSS. The suspension was loaded on a Percoll gradient and centrifuged at 1500 g for 15 
minutes to obtain the Kupffer cells. The isolated cells were plated onto 32mm2 plastic 
dishes for adherence. Qualitative screening for Kupffer cells was carried out with 
immunoreactivity against the CD68 antibody. Cultures with >80% CD68-positive cells 
were used for experiments. 
Kupffer cell culture:105 isolated Kupffer cells were cultured in 24 well plates with 
5 mM BDCM and 100 µg/ml recombinant leptin. Following  24 h incubation, the 
supernatant was collected for analysis of cytokines, and cell lysates were used for DMPO 
nitrone adduct and Nitrotyrosine immunoreactivity.   
Enzyme-linked immunosorbent assay:  Immunoreactivity for DMPO nitrone 
adducts and nitrotyrosine was detected in liver homogenates and Kupffer cell lysates using 
standard ELISA (56). TNF-α and MCP-1release was estimated in serum using ELISA kits 
from BD Pharmingen and Thermo Scientific, respectively, following the manufacturer’s 
protocols.   
Histopathology:  For each animal, sections of liver were collected and fixed in 
10% neutral buffered formalin. For histological examinations, formalin-fixed liver sections 
were stained with hematoxylin/eosin and observed under a light microscope. 
TUNEL Assay: 
Liver tissue from mice were fixed overnight in 10% neutral-buffered formalin (Sigma 
Aldrich, Missouri, USA) and paraffin-embedded sections (5 µm thickness, courtesy 
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Instrumentation Resource Facility, School of Medicine, University of South Carolina, 
USA)  prepared from them were used for TUNEL staining. TACS 2TdT DAB in situ 
Apoptosis Detection Kit was supplied by Trevigen Inc. Maryland, USA. Stained sections 
were imaged under high power (40X, 25.2X magnification) using BX43 microscope and 
DP73 camera from Olympus America Inc., Pennsylvania, USA. 
Western Blotting: 
100mg of tissue from each liver sample was homogenized in 1ml of RIPA buffer (Sigma 
Aldrich) using dounce homogenizer. Homogenate was centrifuged, the supernatant was 
diluted 1:10 and used for western blotting. We used Novex (Invitrogen, California,USA) 4 
– 12% bis-tris gradient gel. Rabbit anti-mouse primary antibodies against  isocitrate 
dehydrogenase (IDH) and β-actin (positive control); and goat anti-rabbit HRP-conjugated 
secondary antibody were obtained from AbCam plc (Massachussetts, USA).  The dilutions 
used were: anti-IDH – 1:1000, anti-β-actin – 1:500, secondary antibody – 1:10000. Trans 
– Blot Turbo transfer system (Bio-Rad Laboratories Inc., California, USA) and precut 
nitrocellulose blotting membrane/filter paper sandwiches (Bio-Rad) were used to perform 
a 7-minute transfer. Pierce ECL Western Blotting substrate (Thermo Fisher Scientific Inc., 
Illinois, USA) was used. BioMax MS Films and cassettes (with intensifying screen) were 
from Kodak. 
Real-Time Reverse Transcription–Polymerase Chain Reaction Analysis: Gene 
expression levels in tissue samples were measured by real-time reverse transcription–
polymerase chain reaction analysis.  Tissue samples (85-100 mg) were taken from each 
liver and individually homogenized using a Tissue Tearor variable speed homogenizer. 
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Total RNA was isolated from homogenates with the use of TRIzol reagent (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instructions and purified with the use of 
RNeasy mini kit columns (Qiagen, Valencia, CA).  Purified RNA was reverse transcribed 
to complementary DNA with the use of Moloney murine leukemia virus reverse 
transcriptase (Applied Biosystems, Foster City, CA) reverse transcriptase and oligo-dT 
primers. Gene-specific primers were designed with the use of Primer Express 3.0 software 
(Applied Biosystems, Foster City, CA).   
The ABsolute SYBR Green ROX Mix (ABgene, Rockford, IL) was used for 
amplifications. Amplification conditions were as follows: 15 minutes at 95oC, followed by 
40 cycles of 95oC for 1 minute and 60oC for 1 minute.  Cycle time (Ct) values for the 
selected genes were normalized to values for 18S in the same sample.  For each liver,  tissue 
samples were collected and tested separately with triplicate Ct values collected each time.  
DIO mouse liver was used as the control for comparison with all other livers.  Ct values 
for all controls were set at 100%.  The sequences for the primers used for RT-PCR are 
provided in 5’ to 3’ orientation.  
TNF:Forward – AGCCCACGTCGTAGCAAACCACCAA,  
Reverse – AACACCCATTCCCTTCACAGAGCAAT. 
 Mcp-1:Forward - CTTCTGGGCCTGCTGTTCA  
Reverse – CCAGCCTACTCATTGGGATCA  
. CD68: Forward- GCTACATGGCGGTGGAGTACAA 
 Reverse – ATGATGAGAGGCAGCAAGATGG. 
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 Immuno-spin trapping of DMPO-protein radicals from cell lysates using 
ELISA:  Kupffer cell lysates for use in ELISA for the detection of DMPO-protein nitrone 
adducts were prepared using a cell sonicator. Since buffers contain traces of metals and 
other contaminants that could form DMPO-protein radicals, we compared chelexed 
phosphate buffer (pH 7.4) containing 100 μM DTPA and RIPA buffer. Results from the 
pilot experiments found no significant difference in the chemiluminescence signal from 
these experiments, and all subsequent lysates were prepared in RIPA buffer (0.05 g sodium 
deoxycholate, 100 µL Triton X-100 and 10 µL of 10% SDS in 10 mL of 0.1 M PBS) 
containing protease inhibitors (Complete, Mini Protease Inhibitor Cocktail Tablets, Roche 
Applied Science, Indianapolis, IN). Following a 30 min incubation of the samples in ice, 
they were centrifuged at 20000 × g for 20 min. The soluble material (supernatant) was 
stored at 4° C until use. 
Confocal laser scanning microscopy (Zeiss LSM 510 UV Meta): DIO obese 
mice were administered carbon tetrachloride to induce metabolic oxidative stress. DMPO 
was injected in two doses of 1 g/kg at 2 h and 1 h prior to sacrifice. Livers were fixed in 
10% neutral buffered formalin and soaked in 30% sucrose for 24 h. The frozen sections 
(10 micron) were cryocut using a frozen tissue processor (Leica Instruments, Bannockburn, 
IL) at the immunohistochemistry core facility at NIEHS. Tissue slices were then treated 
with 0.5% SDS (5 minutes) for antigen retrieval, permeabilized, and blocked (2% nonfat 
dry milk, Pierce Biomedical, Rockford, IL). An antibody specific to DMPO nitrone adducts 
and Alexafluor 568 goat anti-rabbit secondary antibody (Molecular Probes, now 
Invitrogen, Carlsbad, CA) were used as primary and secondary antibodies, respectively. 
Anti-nitrotyrosine antibody was from Abcam. Confocal images were taken on a Zeiss 
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LSM710-UV meta (Carl Zeiss, Inc., Oberkochen, Germany) using a Plan-
NeoFluor 40X/1.3/40XxOil DIC objective with different zoom levels.  
Macrophage depletion by GdCl3: Mice were injected with gadolinium chloride 
(10mg/kg) through the i.v. route, 24 h prior toBDCM treatment, as described by Rai et 
al(1). 
Statistical analyses: All in vivo experiments were repeated three times with 3 mice 
per group (N=3; data from each group of three mice was pooled). All in vitro experiments 
were repeated three times, and the statistical analysis was carried out by analysis of 
variance (ANOVA) followed by the Bonferroni posthoc correction for intergroup 
comparisons. Quantitative data from Western blots as depicted by the relative intensity of 
the bands were analyzed by performing a Student’s t test. P<0.05 was considered 
statistically significant. 
2.3 RESULTS 
Bromodichloromethane acute exposure sensitizes obese liver to increased free radical 
stress. We have shown previously that free radical metabolism of a “second hit” like CCl4 
produces lipid peroxidation and protein radical formation in obesity (8). BDCM is known 
to be metabolized by CYP2E1 and produces dihalomethyl radicals (16). To investigate the 
role of BDCM exposure in causing increased free radical stress in obesity, lipid 
peroxidation was analyzed in the obese liver. 4-hydroxynonenal, (4-HNE) a peroxidation 
product of lipids was measured in whole liver homogenates. Results showed that there was 
a significant increase in 4-HNE adducts in DIO+BDCM group as compared to lean control 
, lean control + BDCM and DIO groups at 6 hours post exposure (P<0.05) (Fig. 2.1A). 
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Further, we analyzed whether the lipid peroxidation led to protein radical formation and 
tyrosine nitration in the obese liver. Results showed that there was a significant increase in 
the protein radical-adduct formation in DIO+BDCM group as compared to lean control, 
lean control+BDCM and DIO groups (P<0.05) (Fig. 2.1B). The protein radical adducts 
localized in the centrolobular region of the liver (Zone 3), a typical hallmark of radical 
based liver injury (16) (Fig. 2.1C). To find whether the protein radicals were primarily due 
to tyrosine radicals,  immunoreactivity against nitrotyrosine was analyzed. Results showed 
that DIO+BDCM group had greater immunoreactivity to 3-nitrotyrosine in the 
centrolobular region when analyzed by confocal laser scanning microscopy, as compared 
to lean control mice treatedwith BDCM (Fig. 2.1D). The CYP2E1 protein levels were also 
increased significantly in DIO+BDCM group when compared to lean control, lean 
control+BDCM and DIO only groups. The HNE adducts and protein radical formation was 
abrogated following use of CYP2E1 inhibitor Diallylsulfide (Data not shown).Since higher 
CYP2E1 levels and resultant metabolic oxidative stress by CYP2E1 yields noxious free 
radicals following BDCM exposure as shown here, the results were indicative of 
potentiation of free radical formation in obesity. 
BDCM acute exposure causes increased leptin levels and contributes to early 
steatohepatitic lesions in obesity. We have shown previously that CYP2E1 metabolism 
and increased free radical formation led to heightened leptin levels in liver (Chatterjee S et 
al, 2012, Journal of Hepatology). To investigate whether BDCM exposure led to increased 
leptin production at the liver and adipose tissues, western blot analysis was performed with 





Figure 2.1 Diet induced obesity potentiates oxidative stress following BDCM exposure in 
mice. A. Immunoreactivity of 4-hydroxynonenal (4-HNE) adducts in mice liver 
homogenates as detected by ELISA. B. Immuno-spin trapping of DMPO nitrone adducts, 
a measure of protein radical formation in mice liver homogenates following BDCM 
exposure, as detected by ELISA. C. Immunolocalization of DMPO nitrone adducts in the 
centolobular region (Zone III) following BDCM exposure. Anti-DMPO immunoreactivity 
is shown in red staining, as detected by confocal laser scanning microscopy. D. 
Immunolocalization of 3-nitrotyrosine adducts, detected by confocal laser scanning 
microscopy in mice exposed to BDCM as shown in green stain. Nuclear stain (DAPI) is 
shown in blue. Results are expressed as mean±SE. Statistical significance was tested using 
ANOVA, with Bonferroni posthoc correction. *(P<0.05)  
of BDCM significantly increased leptin levels in both liver and adipose tissues of DIO 




BDCM exposure also significantly elevated plasma ALT and LDH levels in 
DIO+BDCM mice as compared to lean control, lean control+BDCM and DIO only mice 
(P<0.05) (Fig. 2.2B). This result also emphasizes liver injury with significant non 
programmed cell death as indicated by elevated LDH levels(Fig. 2.2B). To characterize the 
early steatohepatitc lesions in obesity following BDCM exposure, liver histopathology was 
examined and scored as per the histology activity index (HAI) index. Results showed that 
there was significant elevation of HAI scores in DIO+BDCM mice as compared to lean 
controls (Table 2.1). Examination of liver tissue revealed significant leukocyte infiltration, 
increased steatosis and ballooning degeneration at 48 hours post BDCM exposure (Fig. 
2.2C). 
Increased leptin in obesity mediates protein radical and nitrotyrosine 
formation in vivo and in isolated Kupffer cells. Leptin, a proinflammatory adipokine has 
been shown to participate in the inflammatory process associated with steatohepatitic 
lesions in obesity(4, 57). Leptin resistance is key to progression of disease in obesity (57). 
We have shown that CYP2E1 metabolism of CCl4elevates serum leptin levels (Chatterjee 
S et al, 2012, Journal of Hepatology, In Press). To investigate whether increased leptin in 
obesity and following BDCM exposure contributes to protein radical formation and free 
radical stress, we used mice with spontaneous knockout of leptin gene and the leptin 
receptor knockout models (lepr-/-). DMPO-nitrone adduct formation, which exemplifies 
protein radical adducts, was significantly decreased in OB/OB mice and leptin receptor 
knockout mice as compared to DIO mice treated with BDCM (Fig. 2.3A). 3-nitrotyrosine 





Figure 2.2 Diet induced obesity and BDCM co-exposure increases leptin expression and 
contribute to early steatohepatitic lesions. A. Leptin mRNA expression in adipose and liver 
tissues in mice exposed to BDCM. Results are shown as an index of fold increase over lean 
control group. B. Serum levels of liver enzymes, markers of tissue injury and necrosis. 
Serum levels of AST, ALT and LDH, a marker of tissue necrosis are shown in mice that 
were exposed to BDCM. C. HE stained paraffin embedded liver tissue section of mice 
exposed to BDCM. Arrow heads indicate increased leukocyte infiltration, a marker of 
inflammatory microenvironment. Results are expressed as mean±SE. Statistical 





Table 2.1 Histology Activity Index 
 
Table 2.1 Assessment of inflammation scores using Histology Activity Index. H&E slides 
were analyzed for each group namely, Lean control, Lean control+BDCM, DIO and 
DIO+BDCM and ranked blindfoldedly. Inflammation was ranked based on the leukocyte 
infiltration and presence of necrosis with a progressive rank from 0 to 10, with 0 being 
minimal on the scale. Results are expressed as mean±SE
Receptor deficient as compared to DIO mice treated with BDCM (Fig. 2.3B). To show the 
involvement of Kupffer cells in leptin mediated protein radical formation and the 
mechanisms  that underlie redox stress, isolated Kupffer cells from DIO mice were 
incubated with recombinantleptin and BDCM. Results showed that Kupffer cells that were 
incubated with leptin and exposed to BDCM had significantly elevated protein radical 
formation, as compared to apocynin (NADPH oxidase inhibitor)- treated, Tempol 
(Superoxide Dismutase-mimetic compound) -treated, Kupffer cells from mice that were 
deficient in leptin receptor and cells treated with excess DMPO ( spin trap for free radicals) 
(Fig. 2.3C). Confocal laser scanning images also showed decreased protein radical 
formation in isolated Kupffer cells from leptin receptor deficient mice as compared to DIO 




Necrosis: 0 1 1 3±1 
Parenchymal 
Injury 0 1 1 3±1 
Portal 
Inflammation: 0 1 1 4±2 
Grade 
(Inflammation): 4±1 7±3 8±2 15±4 
Stage (Fibrosis): 
0 0 1 1 
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and DIO+BDCM treated groups (Fig. 2.3D). deficient mice as compared to DIO and 
DIO+BDCM treated groups (Fig. 2.3D). The results clearly showed that leptin was 
fundamental in the potentiation of the free radical stress mediated by lipid peroxidation and 
superoxide release from either CYP2E1 or NADPH oxidase (Kupffer cells) in obese mice.  
Increased leptin and BDCM metabolism in obesity activates Kupffer cells and 
p67 translocation, a measure of NADPH oxidase membrane assembly and activation. 
It has been shown by us and others that adipocytokine leptin activates Kupffer cells in acute 
and chronic liver injury (23, 58), Chatterjee S et al, 2012, Journal of Hepatology In press). 
Kupffer cell activation is marked by increased release of TNF-α  and monocyte 
chemoattractant protein-1 (16, 58, 59). Further Kupffer cell has functional NADPH oxidase 
and releases superoxide flux upon activation (Chatterjee S et al, J Hepatology, 2012, In 
Press).  Results showed that isolated Kupffer cells, incubated with BDCM and leptin had 
significant elevation of TNF-α  levels in the supernatant at 24 h as compared to cells 
isolated from DIO only mice (P<0.05), while apocynin, Tempol and excess DMPO 
significantly decreased the release of TNF-α levels as compared to BDCM and leptin 
incubated cells (P<0.05) (Fig. 2.4A). Further, cells isolated from leptin receptor knockout 
mice had significant decrease in TNF-α  levels as compared to the DIO+BDCM+Leptin 
group (Fig. 2.4A).  Real time q-pcr analysis showed a significant increase in CD68, the 
activation marker for Kupffer cells in DIO+BDCM group as compared to lean control, lean 
+BDCM andDIO group. The expression of CD68 was significantly lower in leptin receptor 
knockout and leptin knockout mice livers as compared to DIO+BDCM group (P<0.05) 
(Fig. 2.4B). GdCl3-treated livers of DIO+BDCM group also showed a significant decrease 




Figure 2.3 BDCM exposure-induced oxidative stress is mediated by leptin in diet induced 
obese mice and in isolated Kupffer cells..A Immunoreactivity of protein radical adducts as 
assessed by ELISA in liver homogenates from BDCM exposed diet induced obese mice, 
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leptin receptor and leptin knockout mice. B. Immunoreactivity of protein nitrotyrosine 
adducts as assessed by ELISA in liver homogenates from BDCM exposed diet induced 
obese mice, leptin receptor and leptin knockout mice. C. Kupffer cell protein radical 
adducts following co-incubation of BDCM and leptin, in the presence or absence of 
NADPH oxidase inhibitor apocynin or superoxide dismutase mimetic, Tempol or in the 
presence of excess spin trap DMPO or in cells isolated from leptin receptor deficient mice. 
D. Immunolocalization of DMPO-nitrone adducts in isolated Kupffer cells from diet 
induced obese mice and leptin receptor knockout mice, as assessed by confocal laser 
scanning microscope. Anti-DMPO staining is marked by red and nuclear stain in blue. 
Results are expressed as mean±SE. Statistical significance was tested using ANOVA, with 
Bonferroni posthoc correction. *(P<0.05)
expression was strictly from macrophage origin (P<0.05) (Fig. 2.4B). TNF-α  and MCP-1 
protein levels in livers of DIO +BDCM had a significant increase as measured by western 
blot analysis (Fig. 2.4C) and band quantification (Supplementary Fig. 2.1) when compared 
to lean control, lean +BDCM and DIO groups. Protein levels of these proteins decreased 
significantly in leptin receptor knockout and leptin knockout mice livers as compared to 
the DIO+BDCM group (P<0.05). P67 phox subunit of NADPH oxidase needs to 
translocate to the membrane to align with the GP91 phox subunit for its activation and 
superoxide production. Western blot analysis of membrane fractions of liver homogenates 
of DIO mice that were treated with BDCM and fed with high fat diet had a significant 
increase in p67 translocation as compared to to lean control, lean +BDCM, DIO, leptin 
receptor knockout and leptin knockout mice (P<0.05) (Fig. 2.4D). These results clearly 
show the synergistic effect of leptin and BDCM exposure in promoting Kupffer cell 
activation and NADPH oxidase membrane assembly, two crucial events in progression of 
steatosis to early steatohepatitic lesions in obesity. 
BDCM exposure synergizes with leptin in promoting non-programmed cell 
death and progression of steatosis to early steatohepatitic lesions. One of the key events 
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in early steatohepatitic injury is necrosis and degeneration of hepatocytes (25). To 
investigate the role of BDCM exposure to high fat fed mice in cell death, levels of 
hepatocyte necrotic marker, isocitrate dehydrogenase were measured. Results from 
western blot analyzes indicated that isocitrate dehydrogenase was significantly increased 
in DIO+BDCM group as compared to lean control, DIO only and lean control+BDCM 
groups (P<0.05) (Fig. 2.5A and 2.5B) . Leptin receptor knockout or leptin knockout liver 
homogenates had significant decrease in the isocitrate dehydrogenase levels as compared 
to DIO+BDCM group (P<0.05) (Fig. 2.5A and 2.5B). To evaluate whether there was late 
stage apoptosis following BDCM treatment and it was influenced by the increased leptin 
levels, in situ TUNEL assay was performed. Results from immunohistochemistry for 
TUNEL labeling showed that there was increased apoptosis in DIO mice as compared to 
either DIO+BDCM or leptin receptor knockout or leptin knockout mice (Fig. 2.5C). The 
number of TUNEL positive nuclei were significantly higher in DIO mice as compared 
DIO+BDCM or leptin receptor knockout or leptin knockout mice (P<0.05) (Fig. 2.5D). 
The results assume significance since programed cell death induction as compared to 
necrosis might be viewed as a survival mechanism of hepatocytes in toxin-mediated injury 
(60). Further, the finding of significant increases in Isocitrate Dehydrogenase in 
DIO+BDCM group (Fig. 2.5A) confirmed necrotic injury and non-programed cell death 
following a synergistic role of BDCM and leptin. 
2.4 DISCUSSION 
Acute BDCM exposure in mice that were high fat fed led to increased oxidative stress, 
increased expression of leptin, liver inflammation through Kupffer cell activation, NADPH 




Figure 2.4 BDCM co-exposure in diet induced obese mice causes Kupffer cell activation 
and is mediated by leptin. A. TNF-α levels in supernatants of isolated Kupffer cells 
following co-incubation with BDCM and leptin in the presence or absence of NADPH 
oxidase inhibitor apocynin or superoxide dismutase mimetic, Tempol or in the presence of 
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excess spin trap DMPO or in cells isolated from leptin receptor deficient mice. B.  CD68 
mRNAexpression as assessed by quantitative real time PCR.. C. Western blot analysis of 
TNF-α and MCP-1 in liver homogenates of BDCM exposed diet induced obese mice or 
mice that lacked the leptin receptor or leptin. D. Membrane translocation of NADPH 
oxidase subunit P67 following BDCM exposure in diet induced obese mice and in mice 
that lack either the leptin receptor or leptin. Results are expressed as mean±SE. Statistical 
significance was tested using ANOVA, with Bonferroni posthoc correction. *(P<0.05)
the reductive metabolism of this water disinfection byproduct. These events following 
BDCM exposure are hallmarks of early steatohepatitic injury in the liver and showed 
adherence to the two hit hypothesis and the multi hit paradigm (6, 7). The observations 
showed for the first time that an underlying condition of obesity can potentiate the risk of 
developing steatohepatitis following drinking water disinfection byproduct exposure. 
Assuming that more than 30% of the US population is obese, the results underline a serious 
public health problem not only in this country but in developed and developing nations 
where use of chlorine as a disinfectant is largely used. 
 In spite of stricter regulations of BDCM levels in 
drinking water, chlorine is a widely used disinfection agent across the civilized world. The 
general population is exposed to trihalomethanes through consumption of treated drinking 
water, beverages, and food products, inhalation of contaminated air, and dermal contact 
with treated water (17, 61). BDCM reductive metabolism by CYP2E1 causes free radical 
production and has been shown to generate PBN specific free radicals by ESR (15). 
CYP2E1 has been the primary cyp450 isoform to metabolize BDCM (16). We 
hypothesized that BDCM exposure and the resultant free radical generation starts an 
inflammatory cascade linking oxidative stress and the liver innate immune response. 
Results showed that BDCM formed 4HNE adducts, a lipid peroxidation product at 6 hours 




Figure 2.5 BDCM and leptin mediated cell death mechanisms in diet induced obese liver. 
A. Western blot analysis of isocitrate dehydrogenase, a hepatocyte necrosis marker in liver 
homogenates. Lanes 1-8 represent lean control, lean+BDCM, DIO, DIO+BDCM, DIO 
internal control, Leptin receptor knockout, OB/OB and DIO+BDCM (reference control) 
respectively. B. Band analysis of western blots shown in A. C. Histological examination 
of paraffin embedded liver tissue sections following TUNEL staining of BDCM exposed 
diet induced obese mice in the presence or absence of either leptin or leptin receptor. D. 
Numerical estimate of TUNEL positive nuclei in paraffin embedded liver tissue sections 
when assessed in 10x magnification from BDCM exposed DIO mice and in the absence of 
leptin or leptin receptor. 
 
32 
following free radical generation, BDCM exposure also significantly increased leptin 
mRNA expression in both adipose tissue and liver of high fat fed mice (DIO) (Fig. 2.2A). 
This data was important to finding a strong correlation between obesity, BDCM-induced 
oxidative stress and altered histopathology in the liver. Increased leptin in DIO mice 
coupled with higher release of this adipokine following CCl4 induced NASH caused 
immune cell activation and necrosis in the liver (Chatterjee S et al, Journal of Hepatology, 
in press). Similarly our finding that BDCM caused an increase of leptin mRNA in liver of 
obese mice, over and above the high leptin levels found in obesity, was crucial to find a 
causal effect in BDCM induced early steatohepatic lesions.  
To prove the BDCM-leptin interplay in causing early NASH like symptoms, we 
used both OB/OB mice, a spontaneous knockout for leptin and DB/DB mice that have a 
systemic deletion of the leptin receptor isoform. Cellular effects of leptin are mediated by 
leptin receptor isoforms Ob (long) and Ob (short) and they belong to the IL-6 family of 
receptors and activate the JAK-STAT pathway for their downstream effects (62). Leptin is 
known to mediate oxidative stress by activating NADPH oxidase and formation of 
peroxynitrite (24); Chatterjee S et al, 2012, Journal of Hepatology, In press). Leptin also 
mediates Kupffer cell activation and thus triggers the release of innate immune mediators 
and T cell proliferation, through its actions on liver and other peripheral tissues (19, 63, 
64). Our results of increased release of leptin following BDCM exposure allowed us to 
probe the significance of leptin in BDCM exposed early steatohepatitic lesions. Results 
showed that both whole liver homogenates and isolated Kupffer cells produced protein free 
radicals as measured by the immune-spin trapping technique (Fig. 2.3). The radicals further 
stabilized to form nitrotyrosine adducts, which are formed from either peroxynitrite 
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metabolism or in a direct reaction of peroxidases in presence of nitric oxide (65). 
Nitrotyrosine formation is correlated with immune pathogenesis of many diseases. The 
significant formation of 3-nitrotyrosine indicated a prominent role of BDCM-Leptin 
interplay in the steatohepatitic lesions in DIO mice. Isolated Kupffer cells that were 
incubated with leptin and BDCM, showed increased oxidative stress but oxidative stress 
was significantly decreased in the presence of apocynin, an NADPH oxidase inhibitor or 
Tempol, an SOD mimetic compound or excess DMPO (Fig. 2.3C). Kupffer cells that 
lacked the leptin receptor isoforms had significant decrease in oxidative stress, suggesting 
that the presence of leptin, leptin receptor signaling coupled with BDCM was strongly 
associated with the Kupffer cell reactive oxygen species generation (Fig. 2.3C and D). 
Published literature indicates that oxidative stress in Kupffer cells leads to release of 
proinflammatory cytokines and chemokines that are central to inflammatory disease 
pathogenesis in fatty liver disease (24, 40). We and others have shown that Kupffer cell 
activation by leptin results in a poor outcome in fatty liver disease, leading to NASH like 
symptoms (23, 58) (13) . The release of proinflammatory cytokines and chemotactic 
proteins like TNF-α  and MCP-1 from Kupffer cells lead to activation of inflammatory 
pathways that mediate disease progression in the liver(40). Our results showed that BDCM-
leptin synchrony in vivo and in vitro led to TNF-α  and MCP-1 release (Fig. 2.4). Further 
there was a significant increase in the CD68 protein in liver homogenates following BDCM 
exposure suggesting activation of Kupffer cells (Fig. 2.4). Kupffer cell activation was also 
confirmed by the use of Gdcl3-induced depletion of resident macrophages. GdCl3-treated 
group showed significant decrease in CD68 expression as compared to DIO+BDCM group 
(Fig. 2.4B). Kupffer cell activation in liver disease to either alcohol treatment or NASH 
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pathophysiology is crucial for disease progression. It has been presumed that inflammatory 
events in the Kupffer cells primarily trigger the increased antigen presentation, T cell 
proliferation and amplification of the inflammatory cascade (8, 23). Our results of 
increased oxidative stress, TNF-α and MCP-1 release and increased CD68 in liver confirm 
the Kupffer cell activation in BDCM exposure and show that it is leptin dependent  
Kupffer cell activation and the resultant inflammatory events that follow in liver 
injury lead to cell death. There is evidence where damage associated molecular patterns 
have resulted in hepatocyte necrosis in CCl4 mediated early steatohepatitis (8). Leptin, 
which is found in higher concentrations in obesity due to suspected central leptin resistance 
may contribute to the cell death patterns in the liver. NASH histopathology shows that 
hepatocyte necrosis is a key event in the pathogenesis of disease progression (8, 40, 66). 
We argued that BDCM-induced early steatohepatitic injury will cause hepatic cell death 
and is regulated by leptin and involves its receptor. We also hypothesized that absence of 
leptin would prevent non programmed cell death in hepatic microenvironment. Results 
showed that there was a significant increase in apoptotic nuclei in DIO group whereas 
DIO+BDCM group or the group that had absence of leptin or its receptor showed decreased 
apoptosis in the liver (Fig. 2.5C). Interestingly the levels of Isocitrate Dehydrogenase, a 
hepatocyte marker of necrosis increased significantly in DIO+BDCM group as compared 
to DIO alone or in groups that were devoid of leptin or leptin receptor (Fig. 2.5A and 2.5B). 
These results assumed significance since apoptosis and other programmed cell death 
patterns like autophagy are increasingly being recognized as cell survival mechanisms (60). 
Necrosis, as seen in DIO+BDCM group is a significant event in steatohepatitis of obesity 
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and can also be perceived as leptin dependent in BDCM exposed early steatohepatitic 
lesions. 
Taken together, we showed that BDCM exposure causes early steatohepatitic 
lesions in high fat diet induced obesity and is dependent on higher leptin levels in obesity 
but is exacerbated by the direct effects of BDCM on both adipose tissue and liver in 
producing higher expression of this adipokine. Though leptin is perceived as an 
anorexigenic hormone, a profound rise in the levels of this hormone in obesity due to 
central leptin resistance .The levels of leptin might rise further as a result of a direct effect 
of environmental contaminants like BDCM in causing more hepatic and adipose tissue 
expressions of this molecule, and thus sensitize the obese liver for heightened tissue injury. 
These events of hepatic tissue damage can lead to early steatohepatitic lesions and can 
predispose obese liver to more severe liver disease forms such as NASH and cirrhosis. 
Future studies on chronic exposure of low doses of BDCM might shed light on the disease 
progression of NASH and other inflammatory complications of the liver like autoimmune 
hepatitis and hepatocellular carcinoma. Thus, this first ever report on BDCM-exposed early 
steatohepatitic lesions in obesity might lead to answers to more complex public health 
questions on the environmental link to disease progression in obesity. 
Footnote: “This article may be the work product of an employee or group of 
employees of the National Institute of Environmental Health Sciences (NIEHS), National 
Institutes of Health (NIH), however, the statements, opinions or conclusions contained 
therein do not necessarily represent the statements, opinions or conclusions of NIEHS, NIH 
or the United States government.” 
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Abstract: Recent studies indicate the metabolic oxidative stress, autophagy and 
inflammation are hallmarks of nonalcoholic steatohepatitis (NASH) progression. However 
the molecular mechanisms that link these important events in NASH remain unclear. In 
this study we investigated the mechanistic role of purinergic receptor X7 in modulating 
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autophagy and resultant inflammation in NASH in response to metabolic oxidative stress. 
The study uses two rodent models of NASH. In one of them, a CYP2E1 substrate 
bromodichloromethane is used to induce metabolic oxidative stress and NASH. Methyl 
choline deficient diet feeding is used for the other NASH model. CYP2E1 and P2X7 
receptor gene deleted mice are used to establish their roles in regulating metabolic 
oxidative stress and autophagy. Autophagy gene expression, protein levels, confocal 
microscopy based-immunolocalization of LAMP2A and histopathological analysis were 
performed. CYP2E1-dependent metabolic oxidative stress induced increases in P2X7 
receptor expression, chaperone-mediated autophagy markers LAMP2A and Hsc 70 but 
caused depletion of LC3B protein levels. P2X7 receptor gene deletion significantly 
decreased LAMP2A and inflammatory indicators while significantly increasing LC3B 
protein levels as compared to wild type mice treated with BDCM. P2X7 receptor deleted 
mice were also protected from NASH pathology as evidenced by decreased inflammation 
and fibrosis. Our studies establish that P2X7 receptor is a key regulator of autophagy 
induced by metabolic oxidative stress in NASH, thereby modulating hepatic inflammation. 
Further our findings presented here forms a basis for P2X7 receptor as a potential 
therapeutic target in the treatment for NASH. 
3.1 INTRODUCTION  
Nonalcoholic steatohepatitis (NASH) is associated with metabolic oxidative stress, often 
ascribed to enhanced oxidation of membrane lipids, mitochondrial uncoupling of the 
electron transport chain and higher cytochrome P450 enzyme activity (11, 26, 27). 
Metabolic oxidative stress leads to cellular stress and induce cell death mechanisms which 
modulate inflammatory microenvironment in NASH (8, 28).  
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Cell death mechanisms in disease pathogenesis are synonymous with necrosis, autophagy 
and apoptosis, however much attention is recently focused on the various roles of 
autophagy in cellular processes, inflammation, energy homeostasis and immunity (29, 30). 
In spite of increased attention on autophagy, the mechanisms that control autophagy in 
NASH remain unclear. Autophagy is a central eukaryotic process with many cytoplasmic 
homeostatic roles (30). It is a critical pathway for degradation of intracellular components 
by lysosomes and has established roles in hepatic lipid metabolism, insulin sensitivity and 
cellular injury (31). Autophagy, dependent upon the involvement of the cellular 
components has been classified into macro, micro and chaperone mediated autophagy 
(CMA). It is crucial though, that these processes rely on formation of autophagosomes, 
increased levels of LC3B, fusion of autophagosome with the lysosome and degradation of 
the cellular cargo by lysosomal enzymes (31-34). Interestingly, a recent investigation by 
Lin. et al., report pharmacological promotion of autophagy alleviated steatosis and injury 
in alcoholic and non-alcoholic fatty liver (67). Given the importance of autophagy in 
cellular homeostasis and disease pathogenesis it is also important to study both the inducers 
and regulators of autophagy in a pathological state like NASH. One of the key components 
of the inflammatory microenvironment in various disease pathologies is the ionotrophic 
purinergic receptors (P2 receptors) which respond to the damage associated molecular 
patterns (DAMPs) (35, 36). There is an increased focus on a subclass of these receptors 
(P2X7 receptor) which bind ATP with high affinity and is known to regulate inflammation 
in early steatohepatitic injury in mice (8). Apart from the binding to ATP, P2X7 receptor 
(P2X7r) has been shown to increase NADPH oxidase activity, increase Kupffer cell-MHC 
class II expression and regulate inflammation (8). With increased focus on purinergic 
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receptors, inflammosome activation and autophagy in NASH, we explored the possibility 
of P2X7r as a key regulator of autophagy and the resultant inflammation in NASH. 
The present study utilizes two distinct models of experimental NASH which have been 
established to produce pathology of full blown NASH. The toxin model of NASH utilizes 
co-administration of high fat diet and a low dose environmental toxin 
bromodichloromethane (BDCM) (68, 69). The diet-induced model exposes mice to 
methyl-choline deficient (MCD) diet for 8 weeks (70, 71). In a first ever report we show 
that in both models of NASH there was an increased metabolic oxidative stress, which 
caused higher expression of P2X7 receptors. Oxidative stress induced both early and late 
autophagy proteins and was dependent on the presence of P2X7 receptors. P2X7 receptor 
modulated LC3B protein depletion, an event which is crucial for autophagy. Further 
absence of P2X7 receptors significantly reduced downstream inflammosome activation 
and NASH pathophysiology. The present study also advances our understanding in 
considering P2X7receptor-linked autophagy pathways as potential therapeutic targets in 
NASH. 
3.2 MATERIALS AND METHODS 
Mouse model 
Pathogen-free, custom DIO adult male mice with a C57BL/6J background (Jackson 
Laboratories, Bar Harbor, Maine) were used as models of toxin-induced non-alcoholic 
steatohepatitis (NASH). They were fed with a high fat diet (60% kcal) from 6 weeks to 16 
weeks. All experiments were conducted at the completion of 16-weeks. The animals were 
housed one in each cage before any experimental use. Mice that contained the deleted 
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CYP2E1 gene (cytochrome p450 knockout) (29/Sv-Cyp2e1tm1Gonz/J) (Jackson 
Laboratories) and mice that contained the deleted P2X7r gene (purinergic receptor X7 
knockout) (B6.129P2-P2rx7tm1Gab/J) (Jackson Laboratories) were fed with a high fat diet 
and treated identically to DIO mice. The other set of mice were pathogen-free, adult male 
with a C57BL/6J background fed with methylcholine-deficient (MCD) diet and were used 
as models for diet-induced NASH. They were fed with MCD diet from 8 to 16 weeks. Mice 
that contained the disrupted P2X7r gene were also fed with methylcholine-deficient-diet. 
Mice had ad libitum access to food and water and were housed in a temperature-controlled 
room at 23-24C with a 12-hour light/dark cycle. All animals were treated in strict 
accordance with the NIH Guide for the Humane Care and Use of Laboratory Animals, and 
the experiments were approved by the institutional review board both at NIEHS, Duke 
University and the University of South Carolina at Columbia. 
Induction of liver injury in mice 
DIO mice or high-fat-fed gene-specific knockout mice at 16 weeks were administered 
bromodichloromethane (BDCM) (2.0 mmoles/kg, diluted in olive oil) through the intra-
peritoneal route. However, DIO mice treated with olive oil (diluent of BDCM) were used 
as control. After completion of the treatment, mice of all study groups were sacrificed for 
liver tissue and serum for the further experiments. MCD-diet-fed wildtype or gene specific 
knockout mice were sacrificed at 16 weeks for liver tissue for experiments. However, 





Enzyme-linked immunosorbent assay (ELISA) 
Immunoreactivity for DMPO-nitrone adduct was detected in liver homogenate using 
standard ELISA (56) 
Histopathology: 
Liver tissue sections from each mouse were fixed in 10% neutral buffered formalin. 
Formalin-fixed liver sections were stained with hematoxylin and eosin (H&E) and 
observed under the light microscope. Collagen content in liver tissue was evaluated using 
Sirius red–stained liver sections. Each liver section was stained with Picro-Sirius red 
(Sigma-Aldrich) and counterstained with fast green (Sigma-Aldrich).  
Serum ALT, Alkaline Phosphatase and Albumin levels: 
Blood from DIO, DIO+BDCM and P2X7 receptor deleted mice were collected by cardiac 
puncture and serum was separated by standard techniques. The serum ALT and alkaline 
phosphatase was measured at the clinical chemistry core. Albumin was measured using the 
commercially available kit (Alpha Diagnostic kit, San Antonio, TX).  
Immunohistochemistry: 
Formalin-fixed, paraffin-embedded liver tissue from all the mice groups were cut into 5 
µm thick tissue sections. Each section was deparaffinized using standard protocol. Briefly, 
sections were incubated with xylene twice for 3 min, washed with xylene:ethanol (1:1) for 
3 min and rehydrated through a series of ethanol (twice with 100 %, 95%, 70%, 50%), 
twice with distilled water and finally rinsed twice with phosphate buffered saline (PBS) 
(Sigma-Aldrich, St Louis, MO). Epitope retrieval of deparaffinized sections was carried 
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out using epitope retrieval solution and steamer (IHC-world, Woodstock, MD) following 
manufacturer’s protocol. The primary antibodies were (i) anti- 4-Hydroxynonenal, (ii) anti-
3-Nitrotyrosine, (iii) anti-P2X7r, (iv) anti-GABARAP, (v) anti-LAMP-2A, (vi) anti-MHC 
II, (vii) anti-IL-1β (viii) anti-IFN-γ and (ix) anti-LC3B. Primary antibodies were purchased 
from AbCam Inc. (Massachussetts, USA), Millipore (Temecula, CA), R&D Systems 
(Minneapolis, MN) and used in 1:250 dilutions. Antigen specific immunohistochemistry 
(IHC) were performed using Vectastain Elite ABC kit (Vector Laboratories, Burlingame, 
CA) following manufacturer’s protocols. 3,3’ Diaminobenzedine (DAB) (Sigma-Aldrich) 
were used as a chromogen substrate. Sections were counter-stained by Mayer’s 
hematoxylin (Sigma-Aldrich). Washing with PBS (Sigma-Aldrich) was performed thrice 
between the steps. Sections were mounted in Simpo mount (GBI Labs, Mukilteo, WA) and 
observed under 20X oil objective. Morphometric analysis was done using CellSens 
Software from Olympus America. 
Western blotting: 
30 mg of tissue from each liver sample was homogenized in 100 µl of RIPA buffer (Sigma 
Aldrich) with protease inhibitor (1X) (Pierce, Rockford, IL) using dounce homogenizer. 
The homogenate was centrifuged, the supernatant was diluted 1:5 and used for SDS PAGE 
and subjected to western blotting. Novex (Invitrogen, California, USA) 4–12% bis-tris 
gradient gel was used for SDS PAGE. Proteins were transferred to nitrocellulose membrane 
(i) using precut nitrocellulose/filter paper sandwiches (Bio-Rad Laboratories Inc., 
California, USA) and Trans – Blot Turbo transfer system (Bio-Rad) in case of low 
molecular weight proteins; and (ii) using wet transfer module from Invitrogen in case of 
high molecular weight proteins. 5% non-fat milk solution was used for blocking. Primary 
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antibodies against Hsc 70, GABARAP, LC3B, LAMP-2A, Caspase-1, β-actin (all from 
AbCam Inc.), HMGB-1 (Millipore) at recommended dilutions; and compatible HRP-
conjugated secondary antibodies were used. Pierce ECL Western Blotting substrate 
(Thermo Fisher Scientific Inc., Rockford, IL) was used. The blot was developed using 
BioMax MS Films and cassettes (with intensifying screen, Kodak). The images were 
subjected to densitometry analysis using Lab Image 2006 Professional 1D gel analysis 
software from KAPLEAN Bioimaging Solutions, Liepzig, Germany. 
Quantitative Real Time Polymerase Chain Reaction (qRTPCR): 
Gene expression levels in tissue samples were measured by two step qRTPCR.  Total RNA 
was isolated from liver tissue by homogenization in TRIzol reagent (Invitrogen) according 
to the manufacturer’s instructions and purified with the use of RNeasy mini kit columns 
(Qiagen, Valencia, CA). Purified RNA (1µg) was converted to cDNA using iScript cDNA 
synthesis kit (Bio-rad) following the manufacturer's standard protocol. qRTPCR was 
performed with the gene specific primers using SsoAdvanced SYBR Green supermix (Bio-
rad) and CFX96 thermal cycler (Bio-rad). Threshold Cycle (Ct) values for the selected 
genes were normalized against 18S (internal control) values in the same sample.  Each 
reaction was carried out in triplicates for each gene and for each tissue sample.  DIO mouse 
liver sample was used as the control for comparison with all other liver samples in the 
toxin-induced NASH group and MCS-diet fed mouse liver sample was used as control for 
comparison with all other liver samples of the diet-induced NASH group. The relative fold 
change was calculated by the 2-∆∆Ct method.  The sequences for the primers used for Real 
time PCR are provided below in 5’ to 3’ orientation:  
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Gene Primer sequence 
CYP2E1 Sense: GGCGCATCGTGGTCCTGCAT 
Antisense: CCGCACGTCCTTCCATGTGGG 
P2X7r Sense: GGGACGCTGAAGAACACCTT 
Antisense: CCTAACTTCGTCACCCCACC 
GABARAP Sense: AGAGGAGCATCCGTTCGAGA 
Antisense: CGAGCTTTGGGGGCTTTTTC 
Atg-2A Sense: AACATCCAACGTGCTAGGGG 
Antisense: GGACAGTGGGTGGATCTTGG 
LC3B Sense: GCTGTGAGGACAACAGCAAC 
Antisense: AGTGAGTGAGTGACCAGGGA  
MHC II Sense: TGATTCTGGGGGTCCTCGCCC 
Antisense: CGTGGTCGGCCTCAATGTCGT 
LAMP2A Sense: GTACCTGACAAGGCGACACA 
Antisense: CCCAAGAGACAGCGAATCCA 
TGF-β Sense: CTCACCGCGACTCCTGCTGC 
Antisense: TCGGAGAGCGGGAACCCTCG 
COL-1-α-1 Sense: TGGACGATGGGGCTGGGGAG 
Antisense: GGGTGCCCAGTGGTCGCTTC 
α-SMA Sense: GGAGAAGCCCAGCCAGTCGC 
Antisense: ACCATTGTCGCACACCAGGGC 




Caspase-1 Sense: GGACCCTCAAGTTTTGCCCT 
Antisense: AACTTGAGCTCCAACCCTCG 
IL-1β Sense: CCTCGGCCAAGACAGGTCGC 
Antisense: TGCCCATCAGAGGCAAGGAGGA 
TNF-α Sense: CAACGCCCTCCTGGCCAACG 
Antisense: TCGGGGCAGCCTTGTCCCTT 
IFN-γ Sense: TGCGGGGTTGTATCTGGGGGT 
Antisense: GCGCTGGCCCGGAGTGTAGA 
HMGB-1 Sense: GGACTCTCCTTTAACCGCCA 
Antisense: TTGTGATAGCCTTCGCTGGG 
 
Confocal laser scanning microscopy (Zeiss LSM 510 UV Meta):  
Frozen tissue sections after formalin fixation were analyzed by confocal microscopy using 
Zeiss LSM 510-UV meta (Carl Zeiss, Inc., Oberkochen, Germany) and a Plan-
NeoFluor 40X/1.3 objective with different zoom levels. The primary antibody for LAMP-
2A was obtained from AbCam Inc.; the Cy3-conjugated affinitipure secondary antibody 
was obtained from Jackson Immunoresearch. The BODIPY dye and DAPI used were 
supplied by Molecular Probes. 
Statistical Analyses: 
All in vivo experiments were repeated three times with 3 mice per group (N=3; data from 
each group of three mice were pooled). All in vitro experiments were repeated three times, 
and the statistical analysis was carried out by analysis of variance (ANOVA) followed by 
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the Bonferroni posthoc correction for intergroup comparisons. Quantitative data from 
Western blots as depicted by the relative intensity of the bands were analyzed by 
performing a student’s t test.P<0.05 was considered statistically significant. 
3.3 RESULTS 
Steatohepatitic injury in obese mice is associated with increased metabolic oxidative 
stress. Metabolic oxidative stress in obesity-induced steatohepatitic injury is caused 
following increased CYP2E1 activity, mitochondrial uncoupling of the electron transport 
chain or toxin metabolism following administration of hepatotoxic drugs (8, 10, 72, 73). 
We and others have shown that toxin-induced steatohepatitis models produce metabolic 
oxidative stress (8, 69, 74). The toxin and diet-induced steatohepatitic injury models that 
produce metabolic oxidative stress are relevant to clinical outcomes since NASH patients 
show oxidative stress, and has been hypothesized to augment disease progression (75). Our 
results demonstrate that CYP2E1 increases lipid peroxidation, oxidative and nitrosative 
stress upon steatohepatitic injury. 4-Hydroxynonenal (4-HNE), a marker for lipid 
peroxidation was found to be increased in liver tissues from both the toxin (DIO+BDCM) 
and diet models (MCD-diet fed mice) (Figs. 3.1A i-ii; iv-v; 3.1C) as compared to the 
respective controls (DIO and MC sufficient diet herein referred to as MCS diet). DIO mice 
with deletion of the CYP2E1 gene and administered BDCM showed decreased 4-
hydroxynonenal adducts, when compared to DIO+BDCM only group (Figs. 3.1A ii-iii, 
3.1C). Tyrosine nitration, a marker of oxidative and nitrosative stress, as evidenced by 3-
nitrotyrosine (3NTyr) immunoreactivity was found to be increased in liver tissues from 
both the toxin (DIO+BDCM) and diet models (MCD-diet fed mice) (Figs. 3.1B i-ii; iv-v; 




Figure 3.1 Oxidative stress in high-fat diet and BDCM co-exposed model and MCD model 
is mediated by CYP2E1A. 4-hydroxynonenal, (a marker of lipid peroxidation) 
immunoreactivity in liver slices from DIO, DIO+BDCM, CYP2E1 knockout, Methyl 
choline sufficient diet fed mice (MCS) and Methyl choline deficient diet fed mice(MCD) 
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(i-v) . B. Nitrotyrosine immunoreactivity as shown by immunohistochemistry in liver slices 
(i-v; DIO, DIO+BDCM,CYP2E1 knockout, MCS and MCD Groups).C. Morphometry 
(percentage) of 4-hydroxynonenal reactive cells. D. Morphometry (percentage) of 
nitrotyrosine imunoreactive cells. E. DMPO-nitrone adducts, a marker of protein free 
radicals in toxin model of NASH as assessed by ELISA with anti-DMPO antibody. 
(P<0.05). F and G. CYP2E1 mRNA expression as measured by quantitative real time PCR 
(P<0.05) in toxin-induced and MCD models of NASH. H. Western blot analysis of 
CYP2E1 protein levels. Lanes 1-5 represent DIO, DIO+BDCM, CYP2E1 Knockout, MCS 
and MCD respectively. I. Band quantification of the immunoblots using normalization 
against beta-actin. The western analysis was done using liver homogenates from the 
respective groups. Representative immunoblot is shown. 
of the CYP2E1 gene and administered BDCM showed decreased 3-nitrotyrosine 
immunoreactivity, when compared to DIO+BDCM only group (Figs. 3.1B ii-iii, 3.1D). To 
estimate the extent of protein radical formation and corresponding oxidation, DMPO-
nitrone adducts were measured in the liver homogenates of the toxin-model of 
steatohepatitic injury. Results indicated that DMPO-nitrone adducts were significantly 
increased in DIO+BDCM group as compared to DIO only group (P<0.05)(Fig. 3.1E). 
CYP2E1 deleted mice fed with high fat diet and co-administered BDCM had a significant 
decrease in the nitrone adducts (Fig. 3.1E, P<0.05). Hepatic CYP2E1 mRNA expressions 
showed an increase in DIO+BDCM (not statistically significant) and MCD-diet treated 
mice as compared to DIO or MCS diet fed mice (Figs. 3.1F and G; P<0.05), suggesting 
that increased CYP2E1 expression might play a prominent role in the metabolic oxidative 
stress generation in steatohepatitic injury. The protein levels of CYP2E1 showed small 
increase in DIO+BDCM group when compared to DIO group (not statistically significant) 
but was unchanged in the MCS and MCD groups (Fig. 3.1H). Given the importance of 
P2X7 receptor in innate immunity, inflammation, cell death and disease pathogenesis in 
NASH following its activation, we investigated the role of metabolic oxidative stress in 
modulating the expression of hepatic P2X7 receptors, those might amplify inflammation. 
Gene expression was measured by qRTPCR. Results indicated that there was a significant 
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increase in P2X7 receptor mRNA expression in DIO+BDCM group and MCD-diet fed 
group when compared to DIO and MCS-diet groups (P<0.05)(Figs. 3.2A and 3.2B). 
Deletion of the CYP2E1 gene in mice fed with high fat diet and exposed to BDCM, had 
significant decrease in the P2X7 receptor mRNA expression as compared to DIO+BDCM 
group (P<0.05)(Fig. 3.2A). Similar observations were found in the P2X7 receptor 
immunoreactivity in hepatic tissue. DIO+BDCM group and MCD-diet fed group had 
higher P2X7 receptor levels when compared to DIO only and MCS-diet groups (Figs. 3.2C, 
i-ii, iv-v). Mice that had the deletion of CYP2E1 gene but co-administered with high fat 
diet and BDCM had decreased levels of P2X7 receptors (Fig. 3.2C, iii). Hepatocytes, 
Kupffer cells and liver sinusoidal endothelial cells had increased expression of P2X7 
receptor mRNA in the toxin model as compared to untreated samples.  
CYP2E1-mediated metabolic oxidative stress in steatohepatitic injury induces 
macroautophagy and causes increased expression of chaperone-mediated autophagy-
related proteins. To study the effect of metabolic oxidative stress on the induction of 
autophagy-related proteins in steatohepatitic injury, markers of macro and chaperone-
mediated autophagy were analyzed. Results indicated that mRNA expressions of early 
autophagy genes GABARAP, Atg2A and LC3B; and components of the lysosomal 
translocation complex, LAMP2A and Hsc 70 were significantly elevated in DIO+BDCM 
group and MCD-diet fed group as compared to DIO and MCS-diet fed group respectively 
(Figs. 3.3A and 3.3B)(P<0.05). Mice that had a deletion of CYP2E1 gene and were co-
exposed to high fat diet and BDCM had a significant decrease in early autophagy markers 




Figure 3.2 High-fat diet and BDCM co-exposure, and MCD diet increase expression of 
P2X7r. A and B. mRNA expression of P2X7 receptor as assessed by quantitative real time 
PCR, normalized against DIO and MCS groups. “CYP2E1 KO” represents liver mRNA 
expression from CYP2E1 gene depleted mice fed with high fat diet. (* P<0.05). C. 
Immunohistochemistry of P2X7 receptor protein from liver slices of DIO, DIO+BDCM, 
CYP2E1 KO, MCS and MCD groups. The localization of the receptor positive staining is 




significant change in the expression pattern of Hsc 70 (Fig. 3.3A). LAMP2A mRNA levels 
were decreased in CYP2E1 deleted mice but the change was not significant (Fig. 3.3A).  
Immunoreactivity of early autophagy marker GABARAP (Initiator of the autophagy 
process), LAMP2A, an important constituent of the lysosomal translocation complex were 
increased in livers of steatohepatitic mice in both models of injury. (Figs. 3.3C and 3.3D; 
i-ii, iv-v). Absence of the CYP2E1 gene caused a decrease in the immunoreactivity of both 
GABARAP and LAMP2A, suggesting that metabolic oxidative stress and related oxidized 
proteins caused due to the involvement of CYP2E1 has led to the initiation and sustenance 
of the autophagy process (Figs. 3.3C iii and 3.3D iii.). Hsc 70 which is responsible for 
recognizing and mediating substrate targeting for chaperone-mediated autophagy, was not 
significantly altered in both DIO+BDCM group and MCD-diet group (Figs. 3.3E and 
3.3F)(P<0.05), however the deletion of the CYP2E1 gene had significantly decreased 
levels of Hsc 70 in the toxin model (Figs. 3.3E and 3.3F)(P<0.05), suggesting a possible 
role of CYP2E1 in regulating the Hsc 70 expressions in this model of steatohepatitic injury. 
P2X7 receptor modulates autophagy induced by metabolic oxidative stress in 
steatohepatitic injury. Based on our current findings that show a significant increase in 
P2X7 receptor gene expression upon increased metabolic oxidative stress in NASH 
models, we investigated its role in mediating autophagy and modulating proteins in 
lysosomal translocation complex. mRNA expression of early autophagy inducing genes, 
GABARAP, Atg2A and LC3B were significantly down regulated in P2X7 receptor gene 
deleted mice (a) co-administered with high fat diet+BDCM, and (b) in MCD diet fed mice 
when compared to DIO+BDCM and MCD diet fed groups respectively (Figs. 3.4A and 




Figure 3.3 Metabolic oxidative stress influences autophagy protein profiles in NASH. A, 
B: mRNA expressions of early and late autophagy-related proteins in toxin and diet-models 
of NASH. (*P<0.05) as measured by quantitative real time PCR. Immunoreactivity of 
 
55 
GABARAP (C) and LAMP2A(D) as measured by immunohistochemistry . Panels i,ii,iii,iv 
and v represent, DIO, DIO+BDCM, CYP2E1 KO, MCS and MCD respectively. E and F 
represent the western blot image for Hsc 70 and its corresponding band quantification 
analysis (*P<0.05). The normalization was carried out against the levels of beta-actin in 
the liver homogenates. 
significant players in chaperone mediated autophagy were down regulated in P2X7 
receptor deleted mice, either treated with toxin BDCM or fed with MCD diet, as compared 
to wild type counterparts (P<0.05);(Figs. 3.4A and 3.4B). Western blot analysis of 
GABARAP revealed a significant decrease in the band intensity, signifying a decreased 
GABARAP protein levels in P2X7 gene deleted mice treated with both the toxin and MCD 
diet as compared to the wild type counterparts (P<0.05)(Figs. 3.4C and 3.4D). Interestingly 
P2X7 receptor deleted mice from both DIO+BDCM and MCD-diet groups had 
significantly increased levels of LC3B as compared to their wild type counterparts 
(P<0.05)(Figs. 3.4C and 3.4D). In contrary to the P2X7 receptor gene deleted mice, protein 
levels of LC3B were decreased in DIO+BDCM and MCD diet fed groups as compared to 
DIO and MCS diet fed groups, suggesting LC3B depletion in NASH (Fig. 3.4E). 
Immunohistochemistry of LC3B also showed increased LC3B protein immunoreactivity 
in P2X7 receptor deleted liver as compared to DIO+BDCM only group (Fig. 3.4F). 
LAMP2A protein levels as studied by immunohistochemistry showed a decreased 
immunoreactivity in P2X7 receptor deleted mice, having exposed to toxin or MCD-diet as 
compared to the wild type counterparts (Fig. 3.5A). Since Hsc 70 plays a crucial role in 
recruiting peptides for the lysosomal translocation process and is a key mediator of late 
autophagy, western blot analysis of Hsc 70 was carried out (76, 77). Results showed that 
P2X7 receptor gene deleted mice had a significant decrease in Hsc 70 protein levels as 




Figure 3.4 P2X7 receptor deletion modulates autophagy in NASH. A and B. mRNA 
expressions of early and late autophagy-related proteins in toxin and diet-models of NASH 
(*P<0.05) as measured by quantitative real time PCR in DIO+BDCM and P2X7 receptor 
gene deleted mice, co-exposed to high fat diet and toxin, MCD and P2X7 receptor gene 
deleted mice fed with MCD diet. C. Western blot analysis of GABARAP and LC3B and 
their corresponding band quantification analysis (D),(* P<0.05). E. Western blot analysis 
of LC3B protein in DIO, DIO+BDCM, MCS and MCD liver homogenates. Bands are 
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normalized against beta-actin. F. Immunohistochemistry of LC3B protein in liver slices of 
DIO, DIO+BDCM and P2X7 receptor knockout mice co-exposed to high fat diet and 
BDCM showing perivenular areas. 
demonstrate that P2X7 receptor modulates both the early autophagy and the late chaperone 
mediated lysosomal translocation processes in steatohepatitic injury. 
P2X7 receptor is a key regulator of LAMP2A association with the lysosomal 
membrane during increased metabolic oxidative stress in steatohepatitic injury. To 
show the extent of lysosomal membrane association of LAMP2A, confocal laser scanning 
microscopy was performed. Results showed that there was an increase (3 fold) in the 
number of events of lysosomal membrane (green) associations of LAMP2A (red), as 
evidenced by co-localization spots (yellow) in DIO+BDCM group as compared to DIO 
only group (Fig 3.6A,v-viii). P2X7 receptor deleted mice that were co-administered with 
high fat diet and BDCM had no visible co-localizations in the same numbers of field 
analyzed (Fig. 3.6A, ix-xii).  MCD mice liver had more LAMP-2A-membrane fusions as 
compared to MCS mice as evidenced by confocal microscopy (Fig. 3.6B). These results 
suggested that the absence of P2X7 receptor gene significantly affected LAMP2A 
association with the lysosomal membrane. 
P2X7 receptor modulates autophagy-linked inflammation in NASH: To 
explore the regulation of P2X7 receptor and its downstream effectors in autophagy-linked 
inflammation in steatohepatitic injury, mRNA expression of caspase-1, IL-1β, TNF-α and 
IFN-γ were studied. Results indicated that there was a significant increase (more than 17 
fold) of caspase-1, IL-1β(4 fold), TNF-α and IFN-γ in both DIO+BDCM group and MCD 
diet fed group, as compared to DIO or MCS diet fed group (Figs. 3.7A and 3.7B). Cleaved 




Figure 3.5 Immunodetection of late autophagic gene and chaperone protein. A. 
Immunoreactivity of LAMP2A as analyzed by immunohistochemistry. Panels i-iv 
represent, DIO+BDCM, P2X7 receptor deleted group co-exposed to high fat diet and 
BDCM (toxin), MCD and P2X7 receptor knockout group exposed to MCD diet 
respectively. B and C: Western blot analysis of Hsc70 in DIO+BDCM, P2X7 receptor 
deleted group co-exposed to high fat diet and BDCM (toxin), MCD and P2X7receptor 
deleted group (MCD) (*P<0.05). Fig. 5C represents the band quantification analysis. 
Results also indicated that P2X7 gene deleted mice from both DIO+BDCM co-exposed 
group had decreased amounts of HMGB-1 protein, a damage associated molecular pattern 
linked to inflammation, as analyzed by western blot (Figs. 3.8A and 3.8B), as compared to 
their wild type controls (P<0.05) though the HMGB-1 protein level was not significantly 
different in MCD-treated group (Figs. 3.8A and 3.8B). The decreased expression of 






Figure 3.6 LAMP2A and Bodipy colocalization in high-fat diet and BDCM co-exposed 
model and MCD model. A. LAMP2A colocalization with lysosomal membrane (60x zoom 
3). Confocal laser scanning image of LAMP2A (red) and membrane lipid (Bodipy stain, 
green) from liver sections of DIO, DIO+BDCM and P2X7 receptor deleted group co-
exposed to high fat diet and BDCM. B. LAMP2A colocalization with lysosomal membrane 
(60x). Confocal laser scanning image of LAMP2A (red) and membrane lipid (Bodipy stain, 
green) from liver sections of MCS, MCD and P2X7 receptor deleted group fed with MCD 
diet. Blue arrows show LAMP2A localizations, while white arrows depict colocalizations 
of LAMP2A with lysosomal membrane depicted by green bodipy staining. Number of 
colocalizing events as shown by overlay of images were counted to reveal the extent of 
LAMP2A attachment to the lysosomal membrane. 
metabolic oxidative stress-induced autophagy and corresponding inflammation is regulated 
by the P2X7 receptors in steatohepatitic injury. 
P2X7 receptor gene deleted mice are protected from steatohepatitic injury and 
fibrosis. To ensure that the genetic deletion of P2X7 receptor in mice exposed with either 
high fat diet+BDCM or MCD diet fed group were protected from symptoms of 
steatohepatitic injury, mRNA expressions of fibrotic markers α-SMA, TGF-β and Col-1-
α1 were analyzed. Results showed that α-SMA, TGF-β and Col-1-α1 were significantly 
decreased in P2X7 receptor gene deleted mice as compared to wild type mice either fed 
with high fat diet and BDCM or MCD (Fig. 3.8C, P<0.05). Hemotoxylin and Eosin 
stainings of the liver slices of P2X7 receptor deleted mice administered the toxin and fed 
with high fat diet showed decreased hepatocyte necrosis compared to wild type mice fed 
with high fat diet (Fig. 3.8D).There was a decrease in Picro-Sirius red staining in livers of 
P2X7 receptor gene deleted mice as compared to the wild type mice fed with high fat diet 
and BDCM, suggesting decreased fibrosis (Fig. 3.8E). DIO+BDCM mice also had 
increased serum ALT, Alkaline phosphatase and albumin levels when compared to DIO 




Figure 3.7 P2X7 receptor modulates inflammation in NASH. A. and B. mRNA expression 
of proinflammatory mediators, as measured by quantitative real time PCR in DIO, 
DIO+BDCM, P2X7 receptor gene deleted mice, co-exposed to high fat diet and BDCM 
(toxin), MCS, MCD and P2X7 receptor gene deleted mice fed with MCD diet. The 
expression levels were normalized against DIO in toxin model and MCS in diet model. C. 
Western blot analysis of cleaved caspase-1(active caspase-1) and its corresponding band 
quantification analysis (D), (*P<0.05).Individual lanes representing DIO+BDCM and 
P2X7 receptor gene deleted groups were separated from the parent blot to ensure better 
visibility. E and F: Immunoreactivity of IL-1β and IFN-γ as analyzed by 
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immunohistochemistry. Panels i-vi represent, DIO, DIO+BDCM, P2X7 receptor deleted 
group co-exposed to high fat diet and BDCM (toxin), MCS, MCD and P2X7 receptor 
deleted group exposed to MCD diet respectively.  
 
3.4 DISCUSSION:  
Till date nonalcoholic fatty liver disease and its associated steatohepatitic injury is 
considered an emerging epidemic in light of the dramatic increase in obesity rates (39, 40). 
With the progressive nature of NASH and its rising prevalence there is a significant need 
for specific and targeted treatments. This is complicated by the fact that there are not many 
validated therapies for NAFLD other than weight loss, which is well known to have a poor 
long-term success rate (80). Cellular death pathways and inflammation play crucial roles 
in NASH pathophysiology and it is essential that we identify new mediators of NASH 
pathophysiology that are important regulators of autophagy and inflammatory pathways. 
Impairment of autophagy that is correlated with hepatic lipid accumulation and obesity has 
been found to have a significant impact on progression of NASH (31). There is also a 
perception that agents which augment autophagy can have therapeutic potential in NASH 
(67). However no significant research has been in place that link metabolic oxidative stress, 
autophagy and P2X7 receptors and their crosstalk in modulating disease progression in 
NASH. Targeting a key regulator of each of these components can have benefits in therapy 
of NASH. This study shows that P2X7 receptor, which is upregulated by metabolic 
oxidative stress (Fig. 3.2), serve as a key regulator in modulating the oxidative stress 
induced-autophagy process (Fig. 3.3). P2X7 down regulation in CYP2E1 knockout mice 
coupled with an earlier report by this group that showed extracellular ATP (ligand for 





Figure 3.8 Fibrosis and necrotic damage are mediated by P2X7r in response to DAMPs in 
both high-fat fed and BDCM co-exposed model and MCD model. A: Western blot analysis 
of HMGB-1 from liver homogenates of DIO+BDCM, P2X7 receptor deleted group co-
exposed to high fat diet and BDCM (toxin), MCD and P2X7 receptor deleted group 
exposed to MCD diet respectively . B. represents the band quantification analysis following 
normalization against beta-actin (*P<0.05). C. Quantitative real time PCR analysis of the 
mRNA expression profiles of fibrosis markers in DIO+BDCM, P2X7 receptor deleted 
group co-exposed to high fat diet and BDCM (toxin), MCD and P2X7 receptor deleted 
group exposed to MCD diet respectively (*P<0.05). D.  Hematoxylin and Eosin staining 
of liver sections from DIO+BDCM group and P2X7 gene deleted group co-exposed to 
BDCM and high fat diet. Areas of necrosis are shown in demarcated blue dotted lines and 
arrow heads. E. Picro-sirius red staining for fibrosis in liver sections from DIO+BDCM 
group and P2X7 gene deleted group co-exposed to BDCM and high fat diet. 
CCl4-mediated NASH model, correlates oxidative stress, upregulation of P2X7 receptor 
and its downstream events(8). The P2X7 receptor might modulate the autophagy process, 
by allowing depletion of LC3B, which is supposedly an early autophagy marker (Fig. 
3.4E), while increasing albeit in small proportions Hsc 70 and LAMP2A mRNA levels 
(Figs. 3.3A and 3.3B) and allowing LAMP2A association with the lysosomal membrane, 
(Fig. 3.6). Interestingly, LC3B mRNA levels in NASH models showed a significant 
increase while the protein levels decreased (Figs. 3.3A, 3.3B and 3.4E). The contrasting 
result might point to a translational level regulation and can be explored further. These 
events can be crucial mediators of chaperone mediated autophagy in the hepatic lobe, thus 
increasing inflammation, in a manner perhaps similar to P2X7 receptor mediated release 
of autophagolysosomes/ phagolysosomes into the extracellular matrix causing increase in 
inflammation(81). The above mechanism of release of phagolysosomes to the extracellular 
matrix might be speculative for NASH at this point, but this study certainly proves the 
dependence of depleted LC3B, increased levels of LAMP2A and Hsc 70 on P2X7 receptor 
in both models of experimental NASH. A previous study by our group showed that P2X7 
receptor was crucial for causing Kupffer cell activation and inflammation following release 
of ATP from necrosed hepatocytes in CCl4-mediated early steatohepatitic injury (8). In the 
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present study we show that metabolic oxidative stress which is associated with NASH 
caused an up-regulation of P2X7 receptors (Fig.3.2). Metabolic oxidative stress also, 
mainly characterized by oxidatively modified proteins has been known to induce 
chaperone-mediated autophagy, increased substrate translocation by Hsc 70 towards the 
lysosomal membrane and increased LAMP2A levels (82). Further, P2X7 receptors have 
been associated with autophagy, disruption of normal lysosomal functions and release of 
autophagolysosomes to the extracellular matrix in the microglial cells, causing an increase 
in inflammation (81). Our present study shows that there was a significant down regulation 
of both early and late autophagy proteins including LAMP2A in P2X7 receptor gene 
deleted mice. P2X7 receptor deleted mice also showed decreased release of IL-1 β, IFN-γ 
and HMGB-1(damage associated molecular pattern that contributes to inflammation(83), 
observations that were dependent on significantly less cleaved caspase-1 protein levels, 
implying the possible involvement of P2X7 receptors. This study however falls short on 
exploring the exact molecular mechanism of P2X7 receptor involvement, and to have a 
clear answer whether it is the increased calcium ion-mediated change in lysosomal pH, 
lysosomal functional impairment or expulsion of the lysophagosome to the extracellular 
matrix that caused an increase in the inflammation. The present study also establishes a 
direct correlation between the decreased numbers of LAMP2A-lysosomal membrane 
associations, reduced inflammation and decreased NASH pathophysiology in P2X7 
receptor gene deleted mice (Figs. 3.6, 3.7 and 3.8). These observations assume significance 
since LAMP2A levels and its association with the lysosomal membrane is an important 
step for chaperone mediated autophagy, which occurs late in the autophagy process. Our 
studies showed a depletion of LC3B, a autophagosome protein in NASH pathophysiology 
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(Fig 3.4E), but not in LAMP2A, which is contrary to a study by Fortunato et al that showed 
decreased LAMP2A levels linked to decreased fusion of the autophagosome with the 
lysosome, resulting in necrotic cell death and inflammation (84). This may be due to a 
different mechanism of a dysfunctional lysosomal function when compared to our model 
that primarily evidenced LC3B depletion. Recent studies also link P2X7 receptor to a 
dysfunctional lysosome and autophagy protein LC3B (81, 85). In both cases the fate of the 
cell and its link to immune activation remains a dysregulated lysosomal compartment and 
is regulated by ATP-binding P2X7 receptors in the latter study (85). Interestingly our study 
indicates a significantly decreased LC3B protein levels in DIO+BDCM and MCD diet fed 
livers as compared to DIO and MCS diet fed groups, while absence of P2X7 receptor gene 
elevates the LC3B protein levels (Figs. 3.4C,D and E). This result is important because it 
has been shown that depletion of autophagic protein LC3B enhances caspase-1 activation 
and increase in inflammatory microenvironment (85). We have also found higher caspase-
1 activation and levels of inflammatory indicators IL-1β, TNF-α, IFN-γ and HMGB-1 in 
DIO+BDCM and MCD diet fed groups while a decrease in these indicators was seen in 
P2X7 receptor gene deleted mice (Fig. 3.7). Taken together, the present study provides first 
evidence that P2X7 receptor deletion results in down regulation of autophagy related 
proteins, inflammation and disease pathophysiology in NASH (Figs. 3.7 and 3.8). Having 
significant evidence that P2X7 receptor is a key regulator of autophagy in NASH, it may 
be presumed that targeting the P2X7 receptor or the autophagy process in NASH can 
emerge as a good therapeutic option for the treatment of NASH. It is increasingly becoming 
clear that there are series of studies that promote autophagy as a beneficial mechanism in 
NASH and equal number of studies that conclude autophagy is central in causing NASH, 
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the present study only predicts the role of P2X7 receptor-mediated defective autophagy as 
a cause for inflammation in NASH(86). Translational impact of this study will be enhanced 
with more mechanistic studies in future involving cell specific P2X7 receptor knock downs 
and functional roles of different autophagy proteins in the presence or absence of the P2X7 
receptor. 
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Abstract: 
The molecular events that link NADPH oxidase and induction of toll-like receptor 4 
(TLR4) recruitment to hepatic lipid rafts in nonalcoholic steatohepatitis (NASH) have been 
unclear. We hypothesize that in the liver, NADPH oxidase activation is a key event to 
TLR4 recruitment to lipid rafts, that in turn upregulates NFkB translocation to the nucleus 
and subsequent DNA binding, leading to NASH progression. Results from confocal 
microscopy showed that livers from murine models of NASH and humans had NADPH 
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oxidase activation. NADPH oxidase activation led to the formation of highly reactive 
peroxynitrite as shown by 3-nitrotyrosine formation in diseased livers. Expression and 
recruitment of TLR4 into the lipid rafts were observed to be significantly higher in rodent 
and human NASH. The described phenomenon was NADPH oxidase, p47phox and 
peroxynitrite dependent, since livers from p47phox deficient mice, or mice treated with 
peroxynitrite decomposition catalyst FeTPPS, peroxynitrite-scavenger phenyl boronic acid 
(FBA), had markedly lower TLR4 recruitment into lipid rafts. Mechanistically 
peroxynitrite-induced TLR4 recruitment was linked to increase in IL-1β, sinusoidal injury, 
and Kupffer cell activation while blocking peroxynitrite attenuated NASH symptoms. In 
conclusion, the results strongly suggest that NADPH oxidase-mediated peroxynitrite drove 
TLR-4 recruitment into hepatic lipid rafts and inflammation while use of peroxynitrite 
scavenger FBA in vivo, a novel synthetic molecule having high reactivity with 
peroxynitrite, attenuated inflammatory pathogenesis in NASH.  
4.1 INTRODUCTION  
Nonalcoholic steatohepatitis (NASH) has been studied extensively in preclinical models 
and humans. NASH manifestations range from an early sinusoidal endothelial dysfunction, 
inflammation followed by a defective tissue repair resulting in fibrosis(37-42). Inefficient 
tissue perfusion in the fatty tissue mostly associated with fatty liver and subsequent NASH 
progression can result in recruitment of other cell types including Kupffer cells, sinusoidal 
endothelial cells and circulating lymphocytes, making it a perfect microenvironment for 
forming an inflammatory foci (43).  
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Recent research reports identify an emerging role of toll like receptor 4 in NASH 
pathogenesis(44, 45). Several endogenous mediators like gut derived endotoxin and 
nuclear factor HMGB-1 has been implicated to activate TLR4 signaling leading to NASH 
severity(46, 47). After its discovery in the 1980s, toll like receptor signaling has been in 
the forefront of innate immune signaling and disease pathophysiology (48). TLR4, one of 
the many TLRs discovered since then plays a pivotal role in cytokine release along with its 
adaptor molecules myeloid differentiation primary response gene 88 (MyD88) and TIR-
domain-containing adapter-inducing interferon-β (TRIF). MyD88 was found to work as an 
adaptor for inflammatory signaling pathways downstream of members of the TLR and 
interleukin-1 (IL-1) receptor families(49). Activation of the TLR4 pathway leads to a 
variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), 
mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node 
of inflammatory pathways(49) . Lipopolysaccharide of gram negative bacterial cell walls 
is a strong ligand for TLR4 on the cell membrane. MD-2 is associated with Toll-like 
receptor 4 (TLR4) on the cell surface and enables TLR4 to respond to LPS (50). Deficiency 
of MyD88 or TLR4 in mice have attenuated the development of the disease(51). Though 
oxidative stress via NADPH oxidase has been shown to drive NASH pathogenesis 
especially fibrogenesis and Kupffer cell activation, there is no direct evidence of a single 
mechanism where a specific oxidative species can drive the recruitment of TLR4-mediated 
inflammation in NASH(13, 24, 52). In this study we therefore aim to identify a single 
intracellular reactive nitrative species that may play a distinct role in developing the 
inflammatory pathogenesis in NASH via TLR4 recruitment to hepatic lipid rafts, an early 
yet distinct process in TLR4 activation and downstream signaling. One of the common 
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sources of generation of toxic superoxide radicals may be NADPH oxidase isoforms which 
can be found in both phagocytic and non-phagocytic cells(53). Liver has been shown to be 
a rich source of various NOX isoforms, being present in phagocytic Kupffer cells, stellate 
cells and sinusoidal endothelial cells (39, 52, 54). Out of the various NOX isoforms NOX2 
is primarily present in Kupffer cells and stellate cells whereas NOX1 and NOX4 have been 
found in other liver cell types(52). NOX2 is comprised of several subunits which includes 
the gp91, p22 (membrane subunits), p67, p47 and Rac1 (cytosolic subunits)(53). Upon 
receipt of proper signals, the cytosolic subunits align with their membrane counterparts to 
form an active NADPH oxidase complex which produce superoxide radicals to be released 
in the extracellular space(53). Several laboratories including us have shown the 
involvement of NOX2 in NASH development(13, 24, 54). NOX2 stimulation by high 
leptin results in peroxynitrite generation thus causing Kupffer cell activation in NASH(13). 
NOX2 has also been shown to facilitate recruitment of toll-like receptor 4 to lipid rafts and 
to help in receptor dimerization and its association with MD2 in several inflammatory 
diseases(55). Since there is no evidence of the molecular events that follow NADPH 
oxidase activation concerning the type of reactive species formation and the mechanisms 
that link TLR4 activation, we investigated the role of peroxynitrite in TLR4 activation in 
NASH. Peroxynitrite has been shown to cause cellular senescence and alter 
immunogenicity of proteins while many functional roles of the peroxynitrite species in 
protein nitration in acute and chronic liver diseases has been reviewed(53, 55, 87, 88) . 
Blocking peroxynitrite in vivo with newer and more specific scavengers may provide novel 
therapeutic strategies for NASH complications. 
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In this study we aimed to investigate the molecular mechanisms of TLR4 induction by 
NADPH oxidase, the role of peroxynitrite followed by its effect on sinusoidal injury, 
inflammation, Kupffer cell activation and stellate cell proliferation, all very significant 
events in NASH progression from steatosis, using a high fat diet-induced obesity model 
where hepatotoxin bromodichloromethane was administered to generate oxidative stress, 
a second hit to cause steatohepatitic lesions(69). A second widely used rodent model, that 
is based on feeding methyl-chloine deficient diet was also used. Human NASH livers and 
healthy human control livers were used to corroborate the results from the murine model. 
We used a decomposition catalyst and a scavenger of peroxynitrite to prove the 
involvement of peroxynitrite(13, 53). The results of the study which uses transgenic mice 
and pharmacological approach, show for the first time a molecular basis of NADPH 
oxidase-mediated peroxynitrite-driven TLR4 activation in causing sinusoidal injury, 
inflammation and stellate cell proliferation in NASH. 
4.2 MATERIALS AND METHODS 
Obese mice:   
Pathogen-free, 6 weeks old, custom high fat diet –fed adult male mice with C57BL/6J 
background (the Jackson Laboratory, Bar Harbor, Maine) were used as model for diet 
induced obesity (DIO). The animals were fed with high-fat diet (60% kcal) from 6 weeks 
to 16 weeks. After completion of 16 weeks, all experiments were conducted. Mice which 
contained disrupted p47phox gene(B6.129S2-Ncf1tm1shl N14, from Taconic, Cranbury, 
NJ) (annotated as p47phox KO), and mice with disrupted TLR4 gene (B6.B10ScN-
Tlr4lps-del/JthJ, from the Jackson Laboratory, Bar Harbor, Maine) (annotated as TLR4 
KO) were fed with high fat diet and treated identically to DIO mice. The mice were housed 
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one per cage in a temperature-controlled room at 23-24 °C with a 12-h:12-h light/dark 
cycle with ad libitum access to food and water. All animals had been treated in strict 
accordance with the NIH guideline for Humane Care and Use of Laboratory Animals and 
local IACUC standards. All experiments were approved by the institutional review board 
at NIEHS, Duke University and the University of South Carolina. 
Induction of liver injury in obese mice (Toxin Model): 
Bromodichloromethane (BDCM) (1.0mM/kg, diluted in corn oil) was administered 
through intraperitoneal injection in 16 weeks old high fat-fed wildtype (annotated as 
DIO+BDCM) or specific gene knockout mice. Two doses of BDCM were administered 
per week for four weeks. DIO mice were  injected  with corn oil (diluent of BDCM) to use 
as control (annotated as DIO). After the treatments were complete for all mouse groups, 
the mice were sacrificed for liver tissue for the further experiments. 
Administration of apocynin/FeTPPS/FBA in obese mice (Toxin Model) 
A group of DIO mice was injected with apocynin, an NADPH oxidase inhibitor at a dose 
of 10mg/Kg body weight (group annotated as Apo). A second group of DIO mice was 
injected with a ferric porphyrin complex that is a decomposition catalyst of peroxynitrite, 
at a dose of 30mg/Kg of body weight (group annotated as FeTPPS). A third group of DIO 
mice was injected with phenyl boronic acid, a peroxynitrite scavenger, at a dose of 
50mg/Kg body weight (group annotated as FBA). All these injections were given1 hour 
prior to each BDCM injection over a period of 4 weeks. 
Human tissues: 
Human liver tissues both from NASH and corresponding healthy individuals were obtained 




Liver sections were collected from each animal and fixed in 10% neutral buffer formalin. 
These formalin-fixed, paraffin embedded tissues were cut in 5μm thick sections. These 
sections were deparaffinized (standard protocol) and stained with Picro-Sirius red and were 
observed using 20x objective of light microscope. Stained liver sections were examined 
for stages of fibrosis using the criteria of the NIH Non Alcoholic Steatohepatitis Clinical 
Research Network (NIH NASH CRN) scoring system. Stages of fibrosis were determined 
as 1A: mild, 1C: Portal, 2: Periportal fibrosis and 3: Bridging fibrosis. Briefly, since zone 
3 perisinusoidal/pericellular fibrosis develops first and is followed by portal fibrosis, we 
followed the fibrosis stages as described originally by Kleiner et al(89, 90). Kleiner et al. 
modified the fibrosis staging in the Brunt system by dividing fibrosis scores for stage 1 
into delicate (1a), dense perisinusoidal fibrosis (1b), and non-bridging portal-only fibrosis 
(1c). Stage 2 accounts for perisinusoidal and portal/periportal fibrosis(90). The scoring 
pattern was found to be consistent with portal fibrosis beginning early in the disease 
process and playing an important role in connection with the development of portal–central 
fibrous bridging which is likely found in the most developed cases of fibrosis. 
Immuno-fluorescence microscopy: 
Formalin-fixed, paraffin embedded tissues were cut in 5μm thick sections. Each section 
was subjected to deparaffinization and immunostaining using standard protocol. The 
primary antibodies 1) anti-gp91phox, 2) anti-p47phox, 3) anti-TLR4, and 4) anti-flotillin 
were purchased from Santa Cruz Biotechnologies and Abcam and used at recommended 
dilutions. Species-specific anti-IgG secondary antibodies conjugated with Alexa Fluor 488, 
Alexa Fluor 633, and Alexa Fluor 568 (Invitrogen, California, USA) were used against the 
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appropriate primary antibodies. The sections were mounted in a ProLong gold antifade 
reagent with DAPI. Images were taken under 20X/60Xoil objectives using Olympus BX73 
microscope. Confocal laser scanning microscopy was performed for selected images 
followed by colocalization analysis using LSM software. 
Immunohistochemistry:  
Formalin-fixed, paraffin embedded tissues were cut in 5μm thick sections. Each section 
was subjected to deparaffinization and immunostaining using standard protocol. The 
primary antibodies were 1) anti-IL-1β 2) anti-MCP-1 3) anti-CD68, 4) anti-α-SMA. 
Primary antibodies were purchased from Abcam (Cambridge, MA) and used in 
recommended dilutions.  
Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) was used to perform 
antigen-specific immunohistochemistry following manufacturer’s protocols. 3, 3’ 
Diaminobenzidine (Sigma-Aldrich) was used as a chromogenic substrate. Tissue sections 
were counter-stained by Mayer’s hematoxylin (Sigma-Aldrich).Sections were mounted in 
Simpo mount (GBI Laboratories, Mukilteo, WA) and observed under a 20X objective. 
Morphometric analysis was done using CellSens Software from Olympus America. 
NF-kB transcription factor binding assay: 
Nuclear fraction of each liver sample was isolated following manufacturer’s standard 
protocol (Five photon Biochemicals). DNA binding activity of the transcription factor NF-
kB present in those nuclear extracts was detected by a 96 well enzyme-linked 
immunosorbent assay (ELISA) method (Abcam's NF-kB p65 Transcription Factor Assay 




Statistical Analyses:  
All in vivo experiments were repeated three times with 3 mice per group (N = 3; data from 
each group of three mice was pooled). The statistical analysis was carried out by analysis 
of variance (ANOVA) followed by a post hoc test. Quantitative data from Western blots, 
as depicted by the relative intensity of the bands, were analyzed by performing a Student’s 
t test. P<0.01 and P<0.05 where applicable, was considered statistically significant. 
4.3 RESULTS 
NASH pathogenesis is associated with NADPH oxidase activation-induced 
oxidative stress primarily mediated by peroxynitrite. To study the involvement of 
NADPH oxidase and corresponding oxidative stress in rodent and human livers with 
NASH, experiments were performed to prove the NADPH oxidase activation that is 
characterized by p47phox association with the membrane subunit gp91phox by 
immunostaining and immunofluroscence microscopy. Results showed that DIO+BDCM 
group had a significantly increased colocalization of p47phox and gp91phox in NASH 
livers as compared to DIO only group (Fig.4.1A, ) (Fig.4.1C) (P<0.01). Higher 
magnification image of liver sections showed that colocalization was evident primarily in 
sinusoidal cells and occasional hepatocytes (Fig.4.1A). Gp91phox and p47 phox 
colocalizations were significantly increased in MCD model and human NASH livers 
(Suppl. fig. 4.1A and Suppl fig. 4.1C) (P<0.05). Increased NADPH oxidase activation was 
associated with increased oxidative stress as evident from the increased tyrosyl radical 
formation (3-nitrotyrosine immunoreactivity). Results showed that DIO+BDCM group 
livers had significantly increased immunoreactivity to 3-nitrotyrosine as compared to DIO 
only group (Fig. 4.1B)(P<0.01). Mice that had deleted p47phox gene (p47phox KO) or 
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were treated with NADPH oxidase nonspecific inhibitor apocynin inhibitor or peroxynitrite 
decomposition catalyst FeTPPS or peroxynitrite scavenger FBA showed significantly 
decreased 3-nitrotyrosine immunoreactivity as compared to DIO+BDCM group (Fig. 4.1B  
and Fig. 4.1D) (P<0.01). Livers from MCD diet-fed mice and Human NASH livers showed 
significantly increased immunoreactivity to 3-nitrotyrosine, an index of oxidative stress 
mediated tyrosyl radical formation (Suppl. fig. 4.1B and D) (P<0.05). The results suggested 
that NASH pathogenesis is associated with NADPH oxidase activation primarily via 
NOX2 mediation and p47phox translocation followed by peroxynitrite formation and 
tyrosyl radical formation. FBA scavenging of peroxynitrite also confirmed that 
peroxynitrite was responsible for the tyrosine nitration instead of myeloperoxidase which 
is also present in the injured liver. 
NADPH oxidase activation mediated peroxynitrite formation and subsequent 
oxidative stress drives TLR4 recruitment to hepatic lipid rafts. The role of TLR4 in 
NASH pathogenesis has been reported lately(91, 92). However the mechanisms that drive 
TLR4 recruitment and subsequent signaling in NASH have been unclear. One of the 
primary events of TLR activation is its recruitment to the hepatic lipid rafts following 
which the assembly of activation complex and ligand binding occur(93, 94). Though recent 
studies have focused on TLR4 activation processes primarily by HMGB1, Xbox-1 or 
bacteria from the gut, no studies were featured that show the mechanisms that drive TLR4 
to the membrane rafts(47, 95, 96). To prove that NADPH oxidase mediated peroxynitrite 




Figure 4.1 NADPH oxidase activation and peroxynitrite-mediated tyrosine nitration.  
A: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibodies used: alexafluor568 
(red) against ɑ-gp91phox primary antibody, alexafluor488 (green) against ɑ-p47phox 
primary antibody; nuclear stain (blue) is due to prolong gold antifade reagent with DAPI; 
yellow spots/patches  indicate alignment of cytoplasmic subunit of NADPH oxidase, 
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p47phox (red),  with membrane subunit gp91phox (green); samples from:  high fat-fed  
wild-type mouse , (DIO); high fat-fed wild-type mouse exposed to BDCM (DIO+BDCM). 
B: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibody used: alexafluor633 
(red) against ɑ-3-nitrotyrosine primary antibody; nuclear stain (blue) is due to prolong gold 
antifade reagent with DAPI; samples from: high fat-fed  wild-type mouse (DIO); high fat-
fed wild-type mouse exposed to BDCM (DIO+BDCM); high fat-fed p47phox gene 
knockout mouse exposed to BDCM (p47phox KO); high fat-fed wild-type mouse exposed 
to BDCM and injected with NADPH oxidase inhibitor apocynin (Apo);  high fat-fed wild-
type mouse exposed to BDCM and injected with peroxynitrite decomposition catalyst, a 
ferric porphyrin complex (FeTPPS), high fat-fed wild-type mouse exposed to BDCM and 
injected with peroxynitrite decomposition catalyst phenyl boronic acid (FBA). C: Graph 
depicts morphometry performed on three independent fields for each sample including 
representative images in A captured under 20X magnification lens for gp91phox/p47phox 
co-localization events per 300 cells. D: Graph depicts morphometry performed on three 
independent fields for each sample including representative images in B captured under 
20X magnification lens for percent area showing positive immunoreactivity of 3-
nitrotyrosine calculated in arbitrary units. **P < 0.01. 
 
human livers. Results showed that DIO+BDCM group livers had significant increase in 
TLR4-flotillin (a lipid raft protein) colocalization events as shown by immunofluorescence 
microscopy (6 fold increase) as compared to DIO only group (Fig. 4.2A and 4.2B)(P<0.01). 
Confocal laser scanning imaging (Fig. 4.2C) and analysis (Fig. 4.2D) show colocalization 
of TLR4 and flotillin in sinusoidal cells of NASH livers (Fig. 4.2C). P47phox KO mice 
livers or mice that were treated with NADPH oxidase nonspecific inhibitor Apocynin or 
peroxynitrite decomposition catalyst FeTPPS or peroxynitrite scavenger FBA had 
significantly decreased colocalization events of TLR4 and Flotillin (Fig.4.2A  and 4.2B; 
Suppl. Fig.  4.2A; 20x images). Livers from MCD diet-fed mice or human NASH livers 
showed a significant increase in TLR4-Flotillin co-localization events as compared to 
respective controls (Suppl fig. 4.2B )(Suppl fig. 4.2D)(P<0.05). The results suggest that 
NADPH oxidase activation and subsequent peroxynitrite-mediated oxidative stress drives 
TLR4 recruitment in hepatic lipid rafts, a significant early event of TLR4 signaling and 






Supplementary Figure 4.1 Immunofluorescence images for NADPH oxidase activation and 
3-NT formation in MCD rodent model and human samples. 
4.1A: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibodies used: alexafluor568 
(red) against ɑ-gp91phox primary antibody, alexafluor488 (green) against ɑ-p47phox 
primary antibody; nuclear stain (blue) is due to prolong gold antifade reagent with DAPI; 
yellow spots/patches  indicate alignment of cytoplasmic subunit of NADPH oxidase, 
p47phox (red),  with membrane subunit gp91phox (green); samples from: (i) methionine 
and choline-sufficient diet-fed mouse, annotated as MCS, (ii) methionine and choline-
deficient diet-fed mouse, annotated as MCD, (iii) healthy human control, annotated as Hu 
Ctrl, (iv) human NASH patient, annotated as Hu NASH 
4.1B: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibody used: alexafluor633 
(red) against ɑ-3-nitrotyrosine primary antibody; nuclear stain (blue) is due to prolong gold 
antifade reagent with DAPI; samples from: (i) methionine and choline-sufficient diet-fed 
mouse, annotated as MCS, (ii) methionine and choline-deficient diet-fed mouse, annotated 
as MCD, (iii) healthy human control, annotated as Hu Ctrl, (iv) human NASH patient, 
annotated as Hu NASH 
4.1C: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.1A captured under 20X magnification lens 
for gp91phox/p47phox co-localization events per 300 cells  
4.1D: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.1B captured under 20X magnification lens for 
per cent area showing positive immunoreactivity of 3-nitrotyrosine calculated in arbitrary 
units.  *P<0.01; † P<0.05 
 
NFkB activation and DNA binding in NASH livers require NADPH oxidase 
mediated peroxynitrite upon TLR4 recruitment in lipid rafts. One of the key events 
following TLR4 recruitment from non-rafts to lipid enriched membrane rafts is the down-
stream signaling leading to NFkB activation, translocation to the nucleus and subsequent 
DNA binding(97, 98). Following our observations that NADPH oxidase activation and 
peroxynitrite generation drives TLR4 recruitment to hepatic lipid rafts we probed the 
involvement of NADPH oxidase mediated peroxynitrite in causing NFkB activation. 
Results showed that DIO+BDCM group had significant increase in NFkB activation and 
binding to DNA as compared to DIO group alone (Fig. 4.3A)(P<0.05). Use of p47phox 






Figure 4.2  NADPH oxidase and peroxynitrite – driven TLR4 recruitment to lipid rafts in 
hepatic cell-membranes 
A:  60X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibodies used: alexafluor633 
(red) against ɑ-TLR4 primary antibody, alexafluor488 (green) against ɑ-flotillin primary 
antibody; nuclear stain (blue) is due to prolong gold antifade reagent with DAPI; yellow 
spots/patches  indicate alignment of TLR4 (red),  with lipid raft protein flotillin (green). 
Samples from: high fat-fed  wild-type mouse (DIO); high fat-fed wild-type mouse exposed 
to BDCM (DIO+BDCM); high fat-fed p47phox gene knockout mouse exposed to BDCM 
(p47phox KO); high fat-fed wild-type mouse exposed to BDCM and injected with NADPH 
oxidase inhibitor apocynin (Apo); high fat-fed wild-type mouse exposed to BDCM and 
injected with peroxynitrite decomposition catalyst (FeTPPS), high fat-fed wild-type mouse 
exposed to BDCM and injected with peroxynitrite scavenger phenyl boronic acid (FBA). 
B: Graph depicts morphometry performed on three independent fields for each sample 
including representative images in A captured using 60X magnification lens for 
TLR4/flotillin co-localization events per 300 cells. **P < 0.01. C: Confocal laser scanning 
image of TLR4 and flotillin colocalization in the membranes of liver cells following 
NASH. D: Colocalization analysis using LSM software. 
 
peroxynitrite decomposition catalyst FeTPPS or peroxynitrite scavenger FBA decreased 
the NFkB activation and DNA binding significantly as compared to DIO+BDCM group 
(Fig. 4.3A)(P<0,05). Livers from MCD dietfed mice or human NASH livers had 
significantly increased NFkB activation and DNA binding as compared to their respective 
controls (Fig. 4.3B)(P<0.05). The results suggested that upon TLR4 recruitment to hepatic 
lipid rafts following NADPH oxidase activation, downstream signaling is initiated that led 
to NFkB activation and DNA binding, a significant step towards TLR4-mediated 
inflammatory cytokine release and innate immune activation. 
NADPH oxidase activation and formation of peroxynitrite causes sinusoidal 
injury primarily through their role in TLR4 recruitment. One of the primary events in 
NASH pathogenesis is sinusoidal injury often ascribed to insufficient perfusion and 
formation of inflammatory foci(42, 43, 99). Recent evidences from our laboratory and 
others have shown that sinusoidal injury marked by increases in ICAM-1 and E-Selectin 




Supplementary Figure 4.2 NADPH oxidase and peroxynitrite – driven TLR4 recruitment 
to lipid rafts in hepatic cell-membranes including MCD rodent model and human samples 
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4.2A: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibodies used: alexafluor633 
(red) against ɑ-TLR4 primary antibody, alexafluor488 (green) against ɑ-flotillin primary 
antibody; nuclear stain (blue) is due to prolong gold antifade reagent with DAPI; yellow 
spots/patches  indicate alignment of TLR4 (red),  with lipid raft protein flotillin (green); 
samples from: (i) high fat-fed  wildtype mouse, annotated as DIO; (ii) high fat-fed wildtype 
mouse exposed to BDCM, annotated as DIO+BDCM; (iii) high fat-fed p47phox gene 
knockout mouse exposed to BDCM, annotated as p47phox KO; (iv) high fat-fed wildtype 
mouse exposed to BDCM and injected with NADPH oxidase inhibitor, apocynin, 
annotated as Apo;  (v) high fat-fed wildtype mouse exposed to BDCM and injected with 
peroxynitrite decomposition catalyst, a ferric porphyrin complex, annotated as FeTPPS, 
(vi) high fat-fed wildtype mouse exposed to BDCM and injected with peroxynitrite 
scavenger, phenyl boronic acid, annotated as FBA 
4.2B: 20X magnification representative images of 5µm thick immunostained liver sections, 
imaged using immunofluorescence microscope; secondary antibodies used: alexafluor633 
(red) against ɑ-TLR4 primary antibody, alexafluor488 (green) against ɑ-flotillin primary 
antibody; nuclear stain (blue) is due to prolong gold antifade reagent with DAPI; yellow 
spots/patches  indicate alignment of TLR4 (red),  with lipid raft protein flotillin (green); 
samples from: (i) methionine and choline-sufficient diet-fed mouse, annotated as MCS, (ii) 
methionine and choline-deficient diet-fed mouse, annotated as MCD, (iii) healthy human 
control, annotated as Hu Ctrl, (iv) human NASH patient, annotated as Hu NASH 
4.2C: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.2A captured under 20X magnification lens 
for TLR4/flotillin co-localization events per 300 cells 
4.2D: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.2B captured under 20X magnification lens for 
TLR4/flotillin co-localization events per 300 cells 
 *P<0.01; † P<0.05 
for inflammatory pathogenesis in NASH. Following such observations it was essential that 
the role of NADPH oxidase mediated formation of peroxynitrite and TLR4 recruitment 
into lipid rafts be shown to initiate sinusoidal injury in the NASH liver. Results showed 
that DIO+BDCM group livers had a significant increase in immunoreactivity to ICAM-1 
and E-selectin as compared to DIO only group (Fig. 4.4A,  Fig. 4.4C)(4B,  Fig. 
4.4D)(P<0.01). Use of p47phox KO mice or administration of Apocynin significantly 
decreased the immunoreactivity of ICAM-1 and E-selectin as compared to DIO+BDCM 
group, showing the involvement of NADPH oxidase activation (Fig. 4.4A , 4.4B and 




Figure 4.3 NADPH oxidase and peroxynitrite–driven NFkB translocation and DNA-
binding via TLR4 signaling. A: Graph depicts results of NFkB activation assay in murine 
samples of toxin-induced NASH model; NFkB activation index (assessed from nuclear 
translocation and DNA-binding of p65 subunit) is normalized against DIO sample. B: 
Graph depicts results of NFkB activation assay in murine samples of diet-induced NASH 
model and human samples; NFkB activation index is normalized against appropriate and 
respective control samples. *P < 0.05. 
 
of either peroxynitrite decomposition catalyst FeTPPS or peroxynitrite scavenger FBA 
further decreased the levels of ICAM-1 and E-Selectin in livers as compared to 
DIO+BDCM group (Fig. 4.4A and 4.4B)(P<0.01). Use of mice that are deficient in TLR4 
gene showed significantly decreased levels of ICAM-1 and E-Selectin thus showing a 
strong correlation between NADPH oxidase activation and presence of TLR4 with 
sinusoidal injury as depicted by the increased levels of ICAM-1 and E-Selectin (Fig. 4.4A 
, 4.4B )(P<0.01). MCD diet-fed mouse livers and Human NASH livers showed a significant 
increase in immunoreactivity to ICAM-1 and E-Selectin as compared to their respective 




Figure 4.4  NADPH oxidase and peroxynitrite–driven hepatic sinusoidal injury via TLR4 
signaling. 20X magnification representative images of 5µm thick immunostained liver 
sections, imaged using immunofluorescence microscope; secondary antibody used: 
alexafluor568 (red) against ɑ-ICAM-1 primary antibody (A), and alexafluor568 (red) 
against ɑ-E-selectin primary antibody (B); both ICAM-1 and E-selectin are sinusoidal 
injury markers. A and B: Nuclear stain (blue) is due to prolong gold antifade reagent with 
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DAPI; samples from: high fat-fed  wild-type mouse (DIO); high fat-fed wild-type mouse 
exposed to BDCM (DIO+BDCM); high fat-fed p47phox gene knockout mouse exposed to 
BDCM (p47phox KO); high fat-fed wild-type mouse exposed to BDCM and injected with 
NADPH oxidase inhibitor apocynin (Apo);  high fat-fed wild-type mouse exposed to 
BDCM and injected with peroxynitrite decomposition catalyst, a ferric porphyrin complex 
(FeTPPS), high fat-fed wild-type mouse exposed to BDCM and injected with peroxynitrite 
decomposition catalyst phenyl boronic acid (FBA); high fat-fed TLR4 gene knockout 
mouse exposed to BDCM (TLR4 KO). C:  Graph depicts morphometry performed on three 
independent fields for each sample including representative images in A captured under 
20X magnification lens for percent area showing positive immunoreactivity of ICAM-1, 
calculated in arbitrary units. D:  Graph depicts morphometry performed on three 
independent fields for each sample including representative images in B captured under 
20X magnification lens for percent area showing positive immunoreactivity of E-selectin, 
calculated in arbitrary units. **P < 0.01. 
 
mRNA expression profiles of ICAM-1 and E-Selectin showed a significant increase in 
murine NASH tissues and human NASH tissues while use of gene deficient mice for 
p47phox, TLR4 or administration of peroxynitrite scavengers had significantly decreased 
levels of these sinusoidal injury markers (P<0.05) (Suppl. Figs. 4.4 and 4.5) The results 
suggested that NADPH oxidase activation and subsequent formation of peroxynitrite 
caused increased sinusoidal injury in NASH and were strongly associated to the presence 
of TLR4.  
NADPH Oxidase mediated peroxynitrite generation drives TLR4 signaling 
induced IL-1β, chemokine release and Kupffer cell activation in NASH.  
Previous experiments showed the strong association of NADPH oxidase mediated 
peroxynitrite formation and TLR4 recruitment followed by NFkB activation, crucial 
processes for downstream TLR4 signaling. It is essential that TLR4-mediated IL-1β  
release and Kupffer cell activation that have been shown to be mediated by TLR4 signaling 
be proven to establish the significance of NADPH oxidase driven TLR4 recruitment. 




Supplementary Figure 4.3 Hepatic sinusoidal injury in MCD rodent model and human 
samples. 20X magnification representative images of 5µm thick immunostained liver 
sections, imaged using immunofluorescence microscope; secondary antibody used: 
alexafluor568 (red) against ɑ-ICAM-1 primary antibody (suppl. Fig. 4.3A), and 
alexafluor568 (red) against ɑ-E-selectin primary antibody (suppl. Fig. 4.3C); both ICAM-
1 and E-selectin are sinusoidal injury markers; suppl. Figs. 4.3A & 4.3C: nuclear stain 
(blue) is due to prolong gold antifade reagent with DAPI; samples from (i) methionine and 
choline-sufficient diet-fed mouse, annotated as MCS, (ii) methionine and choline-deficient 
diet-fed mouse, annotated as MCD, (iii) healthy human control, annotated as Hu Ctrl, (iv) 
human NASH patient, annotated as Hu NASH 
4.3B:  graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.3A captured under 20X magnification lens 
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for per cent area showing positive immunoreactivity of ICAM-1, calculated in arbitrary 
units 
4.3D:  graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.3C captured under 20X magnification lens for 
per cent area showing positive immunoreactivity of E-selectin, calculated in arbitrary units.  
*P<0.01; † P<0.05 
 
is significantly higher as compared to DIO only group (Fig. 4.5A, Fig. 4.5D)(P<0.01). 
P47phox KO mice or mice that were treated with peroxynitrite decomposition catalyst 
FeTPPS showed significant decrease in IL-1β  immunoreactivity as compared to 
DIO+BDCM group (Fig. 4.5A , Fig. 4.5D)(P<0.01). TLR4 KO mice showed significant 
decrease in IL-1β  immunoreactivity as compared to DIO+BDCM group suggesting the 
strong involvement of TLR4 signaling (Fig. 4.5A , Fig. 4.5D). MCP-1 release is considered 
a hallmark of Kupffer cell activation and it plays a huge role in liver inflammation to attract 
circulating leucocytes to the inflamed liver in NASH. Results showed that DIO+BDCM 
group had significantly increased MCP-1 immunoreactivity as compared to DIO only 
group (Fig. 4.5B)(P<0.01). P47phox KO mice or mice treated with peroxynitrite 
decomposition catalyst FeTPPS had significantly decreased MCP-1 immunoreactivity as 
compared to DIO+BDCM group (Fig. 4.5B  Fig. 4.5E)(P<0.01). TLR4 KO mice also had 
significant decrease in MCP-1 immunoreactivity as compared to DIO+BDCM group (Fig. 
4.5B and Fig. 4.5E)(P<0.01). The above inflammatory cytokines were also verified for 
their mRNA expression. Results showed that the mRNA expressions of TNF-α, IL-6, 
Lipocalin-2 (Lcn2), serum amyloid A1 (SAA1), IL-1β and MCP-1 were significantly 
increased in rodent and human NASH livers while use of p47 phox KO mice, TLR4 KO 
mice or administration of FeTPPS showed a significant decrease in the expression levels 




Supplementary Figure 4.4 quantitative real time PCR analyses of mRNA levels of ICAM-
1 and E-Selectin in NASH models. 4.4A: ICAM-1 in toxin model of NASH, 4.4B: ICAM-
1 in MCS and MCD model. 4.4C: E-Selectin in toxin model of NASH. 4.4D: E-Selectin in 
MCS and MCD model of NASH.  
† P<0.05 
mediated TLR recruitment in Kupffer cell activation by studying the immunoreactivity of 
CD68 (a Kupffer cell activation marker). Results showed that DIO+BDCM group livers 




Supplementary Figure 4.5 quantitative real time PCR analyses of mRNA levels of 
proinflammatory mediators in Human control and Human NASH livers. TNF-ɑ (4.5A), IL-
6 (4.5B),  Lcn2 (4.5C),  SAA1 (4.5D),  IL-1β (4.5E), MCP1 (4.5F), ICAM-1 (4.5G), E-




4.5C, Fig. 4.5F)(P<0.01) whereas using p47phox KO mice or attenuating formation of 
peroxynitrite significantly decreased CD68 immunoreactivity (Fig. 4.5C  Fig. 
4.5F)(P<0.01). TLR4 KO mice had significantly decreased CD68 immunoreactivity in the 
liver as compared to the DIO+BDCM group suggesting a strong role of TLR4 signaling in 
Kupffer cell activation (Fig.4.5C and 4.5F)(P<0.01). The results strongly suggested that 
NADPH oxidase mediated peroxynitrite that drove TLR4 recruitment was also correlated 
with TLR4 signaling indicated by a significant attenuation of IL-1β  release, MCP-1 and 
CD68 protein levels when administered agents that block NADPH oxidase mediated 
peroxynitrite. The results of decreased IL-1β  release and Kupffer cell activation in TLR4 
KO mice further confirmed the role of TLR4 involvement in NASH inflammatory 
pathogenesis. MCD diet-fed mouse livers and Human NASH livers showed significantly 
decreased IL-1β  (Suppl fig. 4.4A and 4.4D)(P<0.05), decreased MCP-1 levels (Suppl. fig.  
4.4B and 4.4E)(P<0.05) and decreased CD68 immunoreactivity (Suppl. fig. 4.4C and Fig. 
4.4F)(P<0.05) compared to their respective controls thus suggesting that NADPH oxidase 
driven TLR4 recruitment and subsequent NASH inflammatory pathogenesis is prevalent 
across different mouse models and in human form of the disease. 
Recent reports suggest that the strong involvement of TLR4/NFkB pathway in 
migration and activation of hepatic stellate cells is, known to be a hallmark of NASH 
pathogenesis(100)  . To associate the phenomenon of NADPH oxidase driven recruitment 
of TLR4 into hepatic lipid rafts in activating hepatic stellate cells, α -SMA 
immunoreactivity in liver slices were studied by immunohistochemistry. Results showed 
that DIO+BDCM group showed a significant increase in α -SMA immunoreactivity as 




Figure 4.5 TLR4 signaling-mediated cytokine release and Kupffer cell activation. 20X 
magnification representative images of 5µm thick immunostained liver sections, imaged 
using brightfield microscope; positive immunoreactivities (brown) are due to DAB binding 
to respective biotinylated secondary antibodies via streptavidin-HRP; nuclei (blue) 
counterstained with Mayer’s hematoxylin solution; immunoreactivities detected are for 
proinflammatory cytokines: IL-1β(A), MCP-1(B), and Kupffer cell activation marker, 
CD68 (C), respectively. A-C: Samples from: high fat-fed wild-type mouse (DIO); high fat-
fed wild-type mouse exposed to BDCM (DIO+BDCM); high fat-fed p47phox gene 
knockout mouse exposed to BDCM (p47phox KO); high fat-fed wild-type mouse exposed 
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to BDCM and injected with peroxynitrite decomposition catalyst, a ferric porphyrin 
complex (FeTPPS), high fat-fed TLR4 gene knockout mouse exposed to BDCM (TLR4 
KO). D: Graph depicts morphometry performed on three independent fields for each 
sample including representative images in A captured under 20X magnification lens for 
percent area showing positive immunoreactivity of IL-1β, calculated in arbitrary units. E: 
Graph depicting morphometry performed on three independent fields for each sample 
including representative images in B captured under 20X magnification lens for percent 
area showing positive immunoreactivity of MCP-1, calculated in arbitrary units. F: Graph 
depicts morphometry performed on three independent fields for each sample including 
representative images in C captured under 20X magnification lens for percent area showing 
positive immunoreactivity of CD68, calculated in arbitrary units. **P < 0.01 
scavenging peroxynitrite or use of TLR4 KO mice showed significant decrease in α -SMA 
immunoreactivity as compared to DIO+BDCM group (Fig. 4.6A )(Fig. 4.6D)(P<0.01). 
MCD diet-fed mice showed significant increase in α -SMA immunoreactivity as compared 
to MCS group (Fig. 4.6B, Fig. 4.6E)(P<0.05). Human NASH livers had significantly 
increased α -SMA levels as shown by immunohistochemistry when compared with control 
livers from healthy subjects (Fig. 4.6C, 4.6F)(P<0.05). The immunohistochemistry data 
was also verified using western blot analysis of liver tissue homogenates (Suppl. Fig. 
4.9).The data strongly suggested that hepatic stellate cell proliferation depended on the 
NADPH oxidase mediated peroxynitrite formation and its induction of TLR4 recruitment 
into hepatic lipid rafts. NADPH oxidase mediated TLR4 recruitment was also strongly 
correlated with histological assessment of NASH, inflammation, and fibrosis as shown by 
NAS scores (Table 4.1) 
4.4 DISCUSSION 
In this report related to molecular mechanisms of inflammatory pathogenesis in NASH, we 
show that NADPH oxidase-derived peroxynitrite drives TLR 4 recruitment in hepatic lipid 




Supplementary Figure 4.6 quantitative real time PCR analyses of mRNA levels of TNF-ɑ, 
IL-6 and Lcn2 in NASH models.  TNF- ɑ in the toxin model of NASH (6A) and MCS/MCD 
model of NASH (6B). IL-6 in the toxin model of NASH (6C) and MCS/MCD model of 
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NASH (6D). Lcn2 in the toxin model of NASH (6E) and MCS/MCD model of NASH 
(6F). † P<0.05 
 
abrogate the peroxynitrite formation and attenuate IL-1β production, sinusoidal injury, 
Kupffer cell activation and stellate cell proliferation. NASH is clinically silent and is 
presented late in clinics, making it difficult to treat(101, 102). The multiple phases of 
NASH pathogenesis that include an initial lipotoxicity, macrophage activation leading to 
inflammation and a late stage fibrosis, makes devising a therapeutic strategy challenging. 
Thus identification of early molecular signatures of injury initiation in the fatty liver is of 
paramount importance. The recent literature reports of the involvement of TLR4-mediated 
pathways in NASH have identified the molecular basis of inflammation that often precedes 
a late stage fibrosis(102). Since TLR4-mediated inflammation is a sufficiently early event 
in NASH pathophysiology, understanding the molecular basis of its synthesis, recruitment 
to lipid rafts and downstream signaling becomes essential for resolving the disease 
itself(103). Our results, of the strong involvement of NADPH oxidase activation in driving 
TLR4 into the lipid rafts show a novel mechanism of TLR4 activation and NFkB 
translocation in NASH. The results also identify peroxynitrite-mediated TLR4 recruitment 
to lipid rafts as an early molecular event in NASH. The pharmacological approach of using 
a NADPH oxidase inhibitor and use of transgenic mice that lacks the p47phox subunit of 
NADPH oxidase confirm the role of this vital enzyme in lipid raft recruitment of TLR4. 
We have reported previously that NADPH oxidase release of superoxide radicals leads to 
peroxynitrite formation that in turn was instrumental in causing Kupffer cell activation in 
steatohepatitic injury(13). In the present study we used a dual approach to study the 
formation of peroxynitrite via NADPH oxidase, firstly by using a general decomposition 







Supplementary Figure 4.7 quantitative real time PCR analyses of mRNA levels of SAA1, 
IL-1β and MCP-1 in NASH models.  SAA1 in the toxin model of NASH (4.7A) and 
MCS/MCD model of NASH (4.7B). IL-1β in the toxin model of NASH (4.7C) and 
MCS/MCD model of NASH (4.7D). MCP-1 in the toxin model of NASH(4.7E) and (4.7F). 
MCS/MCD model of NASH. † P<0.05.  
 
compound FBA in vivo (104). Modelling human NASH using rodent models remain a 
challenge to the researchers. There is no single model that illustrates the symptoms of 
human NASH in a clear and decisive way(105). Several concepts involving “dual hits” and 
multiple hit paradigms have been proposed but this has been the focus of debate(6, 106). 
The lipotoxicity based model that includes generation of oxidative stress following 
administration of hepatotoxins, a second hit, was previously described by us and others, 
recognizing the fact that it does not reflect the true developmental stages of human NASH 
but represents an underlying condition of steatosis, insulin and leptin resistance that is 
found in human NASH patients(69, 106). Since oxidative stress is undoubtedly a major 
player in human NASH, our model exemplifies a logical approach to study oxidative stress 
mechanisms in the progression of NASH and can be used to test compounds that attenuate 
oxidative stress-mediated inflammation in this disease. On the other hand, use of MCD diet 
model is used widely to depict steatohepatitic lesions coupled with fibrosis, symptoms that 
are found in more progressive stages of human NASH(105, 107, 108). The symptoms 
found in this model represent lesions of human NASH but in a non-insulin resistant state 
though some studies have found hepatic insulin resistance in this model. The results thus 
obtained from these studies reported here may be the beginning of many future studies 
involving NADPH oxidase activation induced TLR4 trafficking and could be validated 





Supplementary Figure 4.8 Immunodetection of IL-1β, MCP-1 AND CD68 in MCD rodent 
models and human samples. 20X magnification representative images of 5µm thick 
immunostained liver sections, imaged using brightfield microscope; positive 
immunoreactivities (brown) are due to DAB binding to respective biotinylated secondary 
antibodies via streptavidin-HRP; nuclei (blue) counterstained with Mayer’s hematoxylin 
solution; immunoreactivities detected are for proinflammatory cytokines: IL-1β(4.8A), 
MCP-1(4.8B), and Kupffer cell activation marker, CD68 (4.8C) respectively; 4.8A, 4.8B 
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&4.8C: samples are from (i) methionine and choline-sufficient diet-fed mouse, annotated 
as MCS, (ii) methionine and choline-deficient diet-fed mouse, annotated as MCD, (iii) 
healthy human control, annotated as Hu Ctrl, (iv) human NASH patient, annotated as Hu 
NASH 
4.8D: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.5A captured under 20X magnification lens 
for per cent area showing positive immunoreactivity of IL-1β, calculated in arbitrary units 
4.8E: graph depicting morphometry done on 3 independent fields for each sample 
including representative images in suppl. fig.4B captured under 20X magnification lens for 
per cent area showing positive immunoreactivity of MCP-1, calculated in arbitrary units 
4.8F: graph depicting morphometry done on 3 independent fields for each sample including 
representative images in suppl. Fig.4C captured under 20X magnification lens for per cent 
area showing positive immunoreactivity of CD68, calculated in arbitrary units . *P<0.01; 
† P<0.05 
 
The dual approach of using two different peroxynitrite blockers was significant since 
FeTPPS and other metaloporphyrins have been used in various rodent models of 
inflammatory diseases but has low oral bioavailability and lacked specificity(53). FBA, an 
aromatic boronate was shown to react specifically with peroxynitrite to yield tyrosine as a 
major product and the probability of formation of nitrotyrosine following a reaction with 
peroxynitrite is negligible because of the stoichiometry of the chemical reaction(109). This 
reaction kinetics made FBA to be a specific scavenger and blocking agent for 
peroxynitrite(109). FBA reacts with peroxynitrite at a rapid rate and stoichiometrically to 
form phenol (k=1.6x106 M-1s-1)(110). FBA is also highly specific to react with 
peroxynitrite and can be used to infer the source of tyrosine nitration since it does not 
inhibit myeloperoxidase-dependent tyrosine nitration. We utilized the effectiveness of 
FBA as a candidate drug to attenuate peroxynitrite mediated recruitment of TLR4 into 
hepatic lipid rafts. Our results of a significant attenuation of TLR4 recruitment to lipid rafts 
as shown by the colocalization of TLR4 and the lipid raft protein, flotillin in NASH livers 
of mice might provide a rationale for using FBA as a future small molecule to attenuate 




Figure 4.6 A-C: Immunohistochemistry images for ɑ-SMA in rodent NASH models and 
human samples. 20X magnification representative images of 5µm thick immunostained 
liver sections, imaged using brightfield microscope; positive immunoreactivities (brown) 
are due to DAB binding to respective biotinylated secondary antibodies via streptavidin-
HRP; nuclei (blue) counterstained with Mayer’s hematoxylin solution; immunoreactivities 
detected are for stellate cell proliferation marker, ɑ-SMA. 4.6 A: Samples are from  high 
fat-fed  wild-type mouse (DIO); high fat-fed wild-type mouse exposed to BDCM 
(DIO+BDCM); high fat-fed p47phox gene knockout mouse exposed to BDCM (p47phox 
KO); high fat-fed wild-type mouse exposed to BDCM and injected with peroxynitrite 
decomposition catalyst, a ferric porphyrin complex (FeTPPS), high fat-fed TLR4 gene 
knockout mouse exposed to BDCM (TLR4 KO). 4.6 B: Samples are from: methionine and 
choline-sufficient diet-fed mouse (MCS), methionine and choline-deficient diet-fed mouse 
(MCD). 4.6 C: Samples are from: healthy human control (Hu Ctrl), human NASH patient 
(Hu NASH). 4.6 D-F: Graphs depict morphometries performed on three independent fields 
for each sample including representative images in 4.6 A (D), B (E), and C (F), captured 
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under 20X magnification lens for percent area showing positive immunoreactivity of ɑ-
SMA, calculated in arbitrary units. **P < 0.01 and  *P < 0.05. 
 
interpreting the findings reported here since FBA has not been used previously in other 
inflammatory disease models. Further FBA treatment also abrogated TLR4-induced NFkB 
translocation and DNA binding, increased levels of sinusoidal injury markers ICAM-1 and 
E-selectin, Kupffer cell activation marker CD68 and stellate cell proliferation. FBA treated 
NASH livers had significantly less fibrosis as assessed by NAS scores. 
Our results further underline an alternate mechanism of lipid raft recruitment of 
TLR4 via an oxidative and nitrative stress pathway, unique in NASH pathophysiology. The 
recruitment of TLR4 might happen as a result of Nrf2 depletion which has a direct effect 
on glutathione synthesizing enzymes and lower levels of glutathione seen in NASH, though 
this remains speculative at this point(111, 112). The results reported here support the role 
of highly reactive peroxynitrite in causing TLR4 trafficking rather than oxyradicals 
generated as a result of TLR4 activation, a concept that has been reported before and is 
widely prevalent in inflammatory diseases(113). Our data supports the peroxynitrite 
mechanism owing to the faster rate kinetics of formation reported for peroxynitrite (1010 
M-1S-1) but the TLR4-induced NADPH oxidase activation in NASH cannot be ruled out 
owing to the complex innate immune regulations associated in the pathophysiology of the 
disease itself(110). 
In summary we showed that TLR-recruitment in lipid rafts is an early event in both 
rodent and human NASH pathogenesis. TLR4-recruitment was initiated by NADPH 
oxidase and the molecular basis of this early event was dependent on the formation of  




Supplementary Figure 4.9 Western blot analysis of alpha smooth muscle actin (α-SMA) in 
liver homogenates from rodent models of NASH and human NASH livers. (9A). 
Immunoblot images for the immunoreactive bands of α-SMA and β-actin. (9B) Band 
analysis after normalizing against β-actin  
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Table 4.1: NASH CRN Scores For NASH Model 
 
Index 1A:Mild; 1C: Portal, Periportal Fibrosis, 3: Bridging Fibrosis 
Table 4.1  NAS Scores for rodent model of NASH. The scores were calculated following 
analysis of histological features of NASH as described by Kleinter et. al and the guidelines 
laid down by the NASH clinical research network. DIO+BDCM group represent the NASH 
model with P47 phox, TLR4 KO mice being the NASH group where the mcie are deficient 
in P47 Phox and TLR4 genes. FBA and FeTPPS represent the mice groups where the 
peroxynitrite scavengers are co-administered with BDCM. 
serve as a new approach to initiate further studies involving relevant rodent models of 
NASH and inflammatory pathogenesis in this disease. This might have significant 
relevance for research in drug development concerning the attenuation of NASH. The study 
is highly significant since we used two different models of NASH, elucidated the formation 
of peroxynitrite and TLR4 lipid raft recruitment in human NASH and avoided in vitro 
cellular experimentation to prove the involvement of peroxynitrite in TLR4 lipid raft 
recruitment, primarily because of the advanced tools to detect peroxynitrite. However, 
caution should be exercised in interpreting some of the results noted in this report since we 
are not aware of the oral bioavailability of this compound and future rodent based studies 
need to focus more on the pharmacokinetics of FBA.   




FeTPPS FBA TLR4 
KO 
Steatosis 2 3 2 2 2 1 
       
Lobular Inflammation 1 3 1 2 0 0 
       
Heaptocyte Ballooning 1 2 2 1 1 0 
       
Stage of Fibrosis 1C 3 1C 1B 1A 1A 
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Acute bromodichloromethane (BDCM) exposure in mice that were high fat fed led to 
increased oxidative stress, increased expression of leptin, liver inflammation through 
Kupffer cell activation, NADPH oxidase membrane assembly, cytokine release and non-
programmed cell death following the reductive metabolism of this water disinfection 
byproduct. These events following BDCM exposure are hallmarks of early steatohepatitic 
injury in the liver and showed adherence to the two hit hypothesis and the multi hit 
paradigm (6, 7). The observations showed for the first time that an underlying condition of 
obesity can potentiate the risk of developing steatohepatitis following drinking water 
disinfection byproduct exposure. Assuming that more than 34% of the US population is 
obese, the results underline a serious public health problem not only in this country but in 
developed and developing nations where use of chlorine as a disinfectant is largely used.
 Findings from Chapter 2 showed that BDCM formed 4HNE adducts, a lipid peroxidation 
product at 6 hours followed by protein free radical formation and stable nitrotyrosine 
adducts in the hepatocytes and Kupffer cells (Fig. 2.1A). Interestingly, following free 
radical generation, BDCM exposure also significantly increased leptin mRNA expression 
in both adipose tissue and liver of high fat fed mice (DIO) (Fig. 2.2A). This data was 
important to finding a strong correlation between obesity, BDCM-induced oxidative stress
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 and altered histopathology in the liver. Increased leptin in DIO mice coupled with higher 
release of this adipokine following CCl4 induced NASH caused immune cell activation and 
necrosis in the liver (Chatterjee S et al, Journal of Hepatology). Similarly our finding that 
BDCM caused an increase of leptin mRNA in liver of obese mice, over and above the high 
leptin levels found in obesity, was crucial to find a causal effect in BDCM induced early 
steatohepatic lesions.  
Our results of increased release of leptin following BDCM exposure allowed us to 
probe the significance of leptin in BDCM exposed early steatohepatitic lesions. Results 
showed that both whole liver homogenates and isolated Kupffer cells produced protein free 
radicals as measured by the immune-spin trapping technique (Fig. 2.3). The radicals further 
stabilized to form nitrotyrosine adducts, which are formed from either peroxynitrite 
metabolism or in a direct reaction of peroxidases in presence of nitric oxide (65). 
Nitrotyrosine formation is correlated with immune pathogenesis of many diseases. The 
significant formation of 3-nitrotyrosine indicated a prominent role of BDCM-Leptin 
interplay in the steatohepatitic lesions in DIO mice. Isolated Kupffer cells that were 
incubated with leptin and BDCM, showed increased oxidative stress but oxidative stress 
was significantly decreased in the presence of apocynin, an NADPH oxidase inhibitor or 
Tempol, an SOD mimetic compound or excess DMPO (Fig. 2.3C). Kupffer cells that 
lacked the leptin receptor isoforms had significant decrease in oxidative stress, suggesting 
that the presence of leptin, leptin receptor signaling coupled with BDCM was strongly 
associated with the Kupffer cell reactive oxygen species generation (Fig. 2.3C and D). 
Published literature indicates that oxidative stress in Kupffer cells leads to release of 
proinflammatory cytokines and chemokines that are central to inflammatory disease 
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pathogenesis in fatty liver disease (24, 40). We and others have shown that Kupffer cell 
activation by leptin results in a poor outcome in fatty liver disease, leading to NASH like 
symptoms (23, 58) (13) . The release of proinflammatory cytokines and chemotactic 
proteins like TNF-α  and MCP-1 from Kupffer cells lead to activation of inflammatory 
pathways that mediate disease progression in the liver(40). Our results showed that BDCM-
leptin synchrony in vivo and in vitro led to TNF-α  and MCP-1 release (Fig. 2.4). Further 
there was a significant increase in the CD68 protein in liver homogenates following BDCM 
exposure suggesting activation of Kupffer cells (Fig. 2.4). Kupffer cell activation was also 
confirmed by the use of Gdcl3-induced depletion of resident macrophages. GdCl3-treated 
group showed significant decrease in CD68 expression as compared to DIO+BDCM group 
(Fig. 2.4B). Kupffer cell activation in liver disease to either alcohol treatment or NASH 
pathophysiology is crucial for disease progression. It has been presumed that inflammatory 
events in the Kupffer cells primarily trigger the increased antigen presentation, T cell 
proliferation and amplification of the inflammatory cascade (8, 23). Our results of 
increased oxidative stress, TNF-α and MCP-1 release and increased CD68 in liver confirm 
the Kupffer cell activation in BDCM exposure and show that it is leptin dependent.  
Kupffer cell activation and the resultant inflammatory events that follow in liver 
injury lead to cell death. There is evidence where damage associated molecular patterns 
have resulted in hepatocyte necrosis in CCl4 mediated early steatohepatitis (8). Leptin, 
which is found in higher concentrations in obesity due to suspected central leptin resistance 
may contribute to the cell death patterns in the liver. NASH histopathology shows that 
hepatocyte necrosis is a key event in the pathogenesis of disease progression (8, 40, 66). 
We argued that BDCM-induced early steatohepatitic injury will cause hepatic cell death 
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and is regulated by leptin and involves its receptor. We also hypothesized that absence of 
leptin would prevent non programmed cell death in hepatic microenvironment. Results 
showed that there was a significant increase in apoptotic nuclei in DIO group whereas 
DIO+BDCM group or the group that had absence of leptin or its receptor showed decreased 
apoptosis in the liver (Fig. 2.5C). Interestingly the levels of Isocitrate Dehydrogenase, a 
hepatocyte marker of necrosis increased significantly in DIO+BDCM group as compared 
to DIO alone or in groups that were devoid of leptin or leptin receptor (Fig. 2.5A and 2.5B). 
These results assumed significance since apoptosis and other programmed cell death 
patterns like autophagy are increasingly being recognized as cell survival mechanisms (60). 
Necrosis, as seen in DIO+BDCM group is a significant event in steatohepatitis of obesity 
and can also be perceived as leptin dependent in BDCM exposed early steatohepatitic 
lesions. 
In my next project recorded in Chapter 3, I have considered the fact that cellular 
death pathways and inflammation play crucial roles in NASH pathophysiology. Thus it is 
essential that I identify new mediators of NASH pathophysiology that are important 
regulators of autophagy and inflammatory pathways. Impairment of autophagy that is 
correlated with hepatic lipid accumulation and obesity has been found to have a significant 
impact on progression of NASH (31). This study shows that P2X7 receptor, which is 
upregulated by metabolic oxidative stress (Fig. 3.2), serve as a key regulator in modulating 
the oxidative stress induced-autophagy process (Fig. 3.3). P2X7 down regulation in 
CYP2E1 knockout mice coupled with an earlier report by this group that showed 
extracellular ATP (ligand for P2X7) release from necrosed-hepatocytes (those that had 
higher 4-HNE staining) in a CCl4-mediated NASH model, correlates oxidative stress, 
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upregulation of P2X7 receptor and its downstream events (8). The P2X7 receptor might 
modulate the autophagy process, by allowing depletion of LC3B, which is supposedly an 
early autophagy marker (Fig. 3.4E), while increasing albeit in small proportions Hsc 70 
and LAMP2A mRNA levels (Figs. 3.3A and 3.3B) and allowing LAMP2A association 
with the lysosomal membrane, (Fig. 3.6). Interestingly, LC3B mRNA levels in NASH 
models showed a significant increase while the protein levels decreased (Figs. 3.3A, 3.3B 
and 3.4E). The contrasting result might point to a translational level regulation and can be 
explored further. These events can be crucial mediators of chaperone mediated autophagy 
in the hepatic lobe, thus increasing inflammation, in a manner perhaps similar to P2X7 
receptor mediated release of autophagolysosomes/ phagolysosomes into the extracellular 
matrix causing increase in inflammation (81). The above mechanism of release of 
phagolysosomes to the extracellular matrix might be speculative for NASH at this point, 
but this study certainly proves the dependence of depleted LC3B, increased levels of 
LAMP2A and Hsc 70 on P2X7 receptor in both models of experimental NASH. 
A previous study by our group showed that P2X7 receptor was crucial for causing 
Kupffer cell activation and inflammation following release of ATP from necrosed 
hepatocytes in CCl4-mediated early steatohepatitic injury (8). In the present study I show 
that metabolic oxidative stress which is associated with NASH caused an up-regulation of 
P2X7 receptors (Fig.3.2). Metabolic oxidative stress also, mainly characterized by 
oxidatively modified proteins has been known to induce chaperone-mediated autophagy, 
increased substrate translocation by Hsc 70 towards the lysosomal membrane and increased 
LAMP2A levels (82). Further, P2X7 receptors have been associated with autophagy, 
disruption of normal lysosomal functions and release of autophagolysosomes to the 
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extracellular matrix in the microglial cells, causing an increase in inflammation (81). My 
present study shows that there is a significant down regulation of both early and late 
autophagy proteins including LAMP2A in P2X7 receptor gene deleted mice. P2X7 
receptor deleted mice also show decreased release of IL-1 β, IFN-γ and HMGB-1(damage 
associated molecular pattern that contributes to inflammation (83), observations that were 
dependent on significantly less cleaved caspase-1 protein levels, implying the possible 
involvement of P2X7 receptors. This study however falls short on exploring the exact 
molecular mechanism of P2X7 receptor involvement, and to have a clear answer whether 
it is the increased calcium ion-mediated change in lysosomal pH, lysosomal functional 
impairment or expulsion of the lysophagosome to the extracellular matrix that caused an 
increase in the inflammation. The present study also establishes a direct correlation 
between the decreased numbers of LAMP2A-lysosomal membrane associations, reduced 
inflammation and decreased NASH pathophysiology in P2X7 receptor gene deleted mice 
(Figs. 3.6, 3.7 and 3.8). These observations assume significance since LAMP2A levels and 
its association with the lysosomal membrane is an important step for chaperone mediated 
autophagy, which occurs late in the autophagy process. My studies show a depletion of 
LC3B, a autophagosome protein in NASH pathophysiology (Fig 3.4E), but not in 
LAMP2A, which is contrary to a study by Fortunato et al that showed decreased LAMP2A 
levels linked to decreased fusion of the autophagosome with the lysosome, resulting in 
necrotic cell death and inflammation (84). This may be due to a different mechanism of a 
dysfunctional lysosomal function when compared to our model that primarily evidenced 
LC3B depletion. Recent studies also link P2X7 receptor to a dysfunctional lysosome and 
autophagy protein LC3B (81, 85). In both cases the fate of the cell and its link to immune 
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activation remains a dysregulated lysosomal compartment and is regulated by ATP-binding 
P2X7 receptors in the latter study (85). Interestingly my study indicates significantly 
decreased LC3B protein levels in DIO+BDCM and MCD diet fed livers as compared to 
DIO and MCS diet fed groups, while absence of P2X7 receptor gene elevates the LC3B 
protein levels (Figs. 3.4C,D and E). This result is important because it has been shown that 
depletion of autophagic protein LC3B enhances caspase-1 activation and increase in 
inflammatory microenvironment (85). I  have also found higher caspase-1 activation and 
levels of inflammatory indicators IL-1β, TNF-α, IFN-γ and HMGB-1 in DIO+BDCM and 
MCD diet fed groups while a decrease in these indicators is seen in P2X7 receptor gene 
deleted mice (Fig. 3.7). Taken together, the present study provides first evidence that P2X7 
receptor deletion results in down regulation of autophagy related proteins, inflammation 
and disease pathophysiology in NASH (Figs. 3.7 and 3.8). Having significant evidence that 
P2X7 receptor is a key regulator of autophagy in NASH, it may be presumed that targeting 
the P2X7 receptor or the autophagy process in NASH can emerge as a good therapeutic 
option for the treatment of NASH. It is increasingly becoming clear that there are series of 
studies that promote autophagy as a beneficial mechanism in NASH and equal number of 
studies that conclude autophagy is central in causing NASH, the present study only predicts 
the role of P2X7 receptor-mediated defective autophagy as a cause for inflammation in 
NASH (86). Translational impact of this study will be enhanced with more mechanistic 
studies in future involving cell specific P2X7 receptor knock downs and functional roles 
of different autophagy proteins in the presence or absence of the P2X7 receptor.  
In the report recorded in Chapter 3, related to molecular mechanisms of 
inflammatory pathogenesis in NASH, I show that NADPH oxidase-derived peroxynitrite 
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drives TLR 4 recruitment in hepatic lipid rafts. Further, I use a novel synthetic peroxynitrite 
scavenger phenyl boronic acid (FBA) to abrogate the peroxynitrite formation and attenuate 
IL-1β production, sinusoidal injury, Kupffer cell activation and stellate cell proliferation. 
NASH is clinically silent and is presented late in clinics, making it difficult to treat (101, 
102). The multiple phases of NASH pathogenesis that include an initial lipotoxicity, 
macrophage activation leading to inflammation and a late stage fibrosis, makes devising a 
therapeutic strategy challenging. Thus identification of early molecular signatures of injury 
initiation in the fatty liver is of paramount importance. The recent literature reports of the 
involvement of TLR4-mediated pathways in NASH have identified the molecular basis of 
inflammation that often precedes a late stage fibrosis (102). Since TLR4-mediated 
inflammation is a sufficiently early event in NASH pathophysiology, understanding the 
molecular basis of its synthesis, recruitment to lipid rafts and downstream signaling 
becomes essential for resolving the disease itself (103). Our results, of the strong 
involvement of NADPH oxidase activation in driving TLR4 into the lipid rafts show a 
novel mechanism of TLR4 activation and NFkB translocation in NASH. The results also 
identify peroxynitrite-mediated TLR4 recruitment to lipid rafts as an early molecular event 
in NASH. The pharmacological approach of using a NADPH oxidase inhibitor and use of 
transgenic mice that lacks the p47phox subunit of NADPH oxidase confirm the role of this 
vital enzyme in lipid raft recruitment of TLR4. Our lab has reported previously that 
NADPH oxidase release of superoxide radicals leads to peroxynitrite formation that in turn 
was instrumental in causing Kupffer cell activation in steatohepatitic injury (13). In the 
present study I use a dual approach to study the formation of peroxynitrite via NADPH 
oxidase, firstly by using a general decomposition catalyst FeTPPS and secondly by helping 
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peroxynitrite react with a novel boronic compound FBA in vivo (104). Modelling human 
NASH using rodent models remain a challenge to the researchers. There is no single model 
that illustrates the symptoms of human NASH in a clear and decisive way (105). Several 
concepts involving “dual hits” and multiple hit paradigms have been proposed but this has 
been the focus of debate (6, 106). The lipotoxicity based model that includes generation of 
oxidative stress following administration of hepatotoxins, a second hit, was previously 
described by us and others, recognizing the fact that it does not reflect the true 
developmental stages of human NASH but represents an underlying condition of steatosis, 
insulin and leptin resistance that is found in human NASH patients (69, 106). Since 
oxidative stress is undoubtedly a major player in human NASH, our model exemplifies a 
logical approach to study oxidative stress mechanisms in the progression of NASH and can 
be used to test compounds that attenuate oxidative stress-mediated inflammation in this 
disease. On the other hand, use of MCD diet model is used widely to depict steatohepatitic 
lesions coupled with fibrosis, symptoms that are found in more progressive stages of 
human NASH (105, 107, 108). The symptoms found in this model represent lesions of 
human NASH but in a non-insulin resistant state though some studies have found hepatic 
insulin resistance in this model. The results thus obtained from these studies reported here 
may be the beginning of many future studies involving NADPH oxidase activation induced 
TLR4 trafficking and could be validated using other models of NASH.  
The dual approach of using two different peroxynitrite blockers was significant 
since FeTPPS and other metaloporphyrins have been used in various rodent models of 
inflammatory diseases but has low oral bioavailability and lacked specificity (53). FBA, 
an aromatic boronate has been shown to react specifically with peroxynitrite to yield 
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tyrosine as a major product and the probability of formation of nitrotyrosine following a 
reaction with peroxynitrite is negligible because of the stoichiometry of the chemical 
reaction (109). This reaction kinetics made FBA to be a specific scavenger and blocking 
agent for peroxynitrite (109). FBA reacts with peroxynitrite at a rapid rate and 
stoichiometrically to form phenol (k=1.6x106 M-1s-1)(110). FBA is also highly specific to 
react with peroxynitrite and can be used to infer the source of tyrosine nitration since it 
does not inhibit myeloperoxidase-dependent tyrosine nitration. We utilized the 
effectiveness of FBA as a candidate drug to attenuate peroxynitrite mediated recruitment 
of TLR4 into hepatic lipid rafts. My  results of a significant attenuation of TLR4 
recruitment to lipid rafts as shown by the colocalization of TLR4 and the lipid raft protein, 
flotillin in NASH livers of mice might provide a rationale for using FBA as a future small 
molecule to attenuate TLR4 mediated inflammation in NASH. However caution should be 
exercised before interpreting the findings reported here since FBA has not been used 
previously in other inflammatory disease models. Further FBA treatment also abrogated 
TLR4-induced NFkB translocation and DNA binding, increased levels of sinusoidal injury 
markers ICAM-1 and E-selectin, Kupffer cell activation marker CD68 and stellate cell 
proliferation. FBA treated NASH livers had significantly less fibrosis as assessed by NAS 
scores. 
The results further underline an alternate mechanism of lipid raft recruitment of 
TLR4 via an oxidative and nitrative stress pathway, unique in NASH pathophysiology. The 
recruitment of TLR4 might happen as a result of Nrf2 depletion which has a direct effect 
on glutathione synthesizing enzymes and lower levels of glutathione seen in NASH, though 
this remains speculative at this point (111, 112). The results reported here support the role 
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of highly reactive peroxynitrite in causing TLR4 trafficking rather than oxyradicals 
generated as a result of TLR4 activation, a concept that has been reported before and is 
widely prevalent in inflammatory diseases (113). My data supports the peroxynitrite 
mechanism owing to the faster rate kinetics of formation reported for peroxynitrite (1010 
M-1S-1) but the TLR4-induced NADPH oxidase activation in NASH cannot be ruled out 
owing to the complex innate immune regulations associated in the pathophysiology of the 
disease itself (110). 
In summary I show that TLR-recruitment in lipid rafts is an early event in both 
rodent and human NASH pathogenesis. TLR4-recruitment is initiated by NADPH oxidase 
and the molecular basis of this early event is dependent on the formation of peroxynitrite. 
The use of FBA as a novel compound to attenuate peroxynitrite in vivo might serve as a 
new approach to initiate further studies involving relevant rodent models of NASH and 
inflammatory pathogenesis in this disease. This might have significant relevance for 
research in drug development concerning the attenuation of NASH. The study is highly 
significant since I used two different models of NASH, elucidated the formation of 
peroxynitrite and TLR4 lipid raft recruitment in human NASH and avoided in vitro cellular 
experimentation to prove the involvement of peroxynitrite in TLR4 lipid raft recruitment, 
primarily because of the advanced tools to detect peroxynitrite. However, caution should 
be exercised in interpreting some of the results noted in this report since we are not aware 
of the oral bioavailability of this compound and future rodent based studies need to focus 
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